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ABSTRACT 
 
 
Epithelial cells, the major target of adult cancers have served as in vitro culture 
models for cancer related research for many years.  Despite the increased use of these 
models, their potential as a cell-based screening tool for therapeutics has been hampered 
by the lack of existing miniaturized platforms that can: (1) facilitate single cell analysis (2) 
support cell cultivation in a physiological context, and (3) enable parallelization for high-
throughput screening.  Recent advancements in microfabrication technology has led to 
the development of miniaturized systems capable of handling very small (microliter – 
nanoliter) volumes of fluid, biomaterials, and bioparticle solutions.   
The central goal of this thesis was to develop miniaturized technologies that 
transcend the limitations of conventional macroscopic two-dimensional culture systems, 
by approaching the native environment of cells in vivo through technologies that allow 
direct screening of cultivated cells with drugs and targeted therapeutics in an appropriate 
context.  To this end, we have developed miniaturized cell culture platforms towards 
three distinct applications: breast cancer research, liver biology/pathology, and studies of 
hepatitis B viral replication.  Pertaining to breast cancer research, we have developed new 
techniques to create micropatterns of the most popular biomatrix for 3D epithelial cell 
culture (Matrigel).  Moreover, we demonstrated that the micropatterned matrix can 
support the 3D cultivation of normal and breast cancer cell lines with comparable 
phenotypes to standard 3D culture techniques.  In addition, by combining this 
micropatterned Matrigel with microfluidic techniques, we were able to develop a new 
platform to study individual cancer cell migration and invasion. 
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Unlike previous demonstrations of micro-scale 3D systems that rely on just coating 
surfaces with thin layers of matrices, we took an approach that fully recapitulates 
standard 3D culture assays, where cells are totally embedded or overlayed with ECM to 
mimic the 3D microenvironment necessary to establish tissue-specific functions as well 
as mechanical and structural signals.  Our development of a microfabricated platform for 
studying breast cancer cells can not only recapitulate normal epithelial structure and 
function but can also allow for more detailed understanding of tissue dysfunction in 
disease states and provides a more realistic milieu for modeling therapeutic intervention. 
We have also developed a novel “mini-liver” culture system using a microfluidic 
platform that simulates the basic functional unit of the liver (the hepatic sinusoid).  The 
microfluidic platform is composed of a layered co-culture of hepatocytes and sinusoidal 
endothelial cells (the two major cell types in the liver) in a microchannel that mimics the 
liver sinusoid.  Unlike previous liver models that rely on the culture of hepatocytes alone 
or random co-culture of hepatocytes with other cell types, we have developed a more 
realistic model that recreates important aspects of the liver including the architecture, 
fluidic environment, and more importantly the cellular composition. Moreover, we 
demonstrated the utility of our microchannel-based platform for meaningful biological 
experiments; we developed a microfluidic based in vitro assay for studying hepatitis B 
viral replication in hepatocytes.  This platform will find many useful applications in 
fundamental liver biology research, viral-mediated liver cancer studies, as well as 
potential use as a novel pharmaceutical platform for epithelial-based screening of genes 
and targeted cancer therapeutics. 
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THESIS SCOPE AND FORMAT 
Microfabrication and microfluidic technologies were used to study various 
aspects of cell biology.  Techniques such as photolithography, soft lithography, and 
surface modification were used to develop miniaturized cell culture systems.  The 
objective of this thesis was to develop microfabricated platforms towards three distinct 
applications: breast cancer research, liver biology/pathology, and hepatitis B viral 
replication studies.   
This thesis is divided into two main sections (excluding introduction, overarching 
discussion, and conclusion) comprised of seven chapters.  Each chapter is written as a 
complete story in order to allow the reader to quickly focus on a particular topic.  
Chapter 1 provides the background for the work and introduces the previous research 
regarding various aspects of the project.  The next three chapters provide the contents for 
Section 1.  Chapter 2 shows the use of soft lithography techniques to micropattern 
Matrigel for use in three-dimensional cell cultivation of normal and breast cancer cells.  
Chapter 3 builds on work done in chapter 2 and demonstrates the use of the 
micropatterned Matrigel for cancer cell migration and invasion studies.  Chapter 4 
provides a mathematical and computational analysis of work done in Chapter 3 by 
modeling the migration and invasion of single cancer cells towards a concentration 
gradient.  Section 2 is comprised of the next two chapters.  It discusses the need for 
authentic liver models for basic liver biology, hepatitis B viral replication, and drug 
screening purposes.  Chapter 5 provides background and design considerations for 
building an authentic liver model.  It demonstrates the development of a layered co-
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culture model mimicking the functional unit of the liver (the hepatic sinusoid).  Chapter 
6 demonstrates the utilization of a microfluidic channel for studying hepatitis B viral 
replication.  Finally, Chapter 7 provides an outline of the conclusions, research 
contributions/discussions, and recommends directions for future work.  
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CHAPTER 1. BACKGROUND AND INTRODUCTION 
1.1 Motivation 
Microtechnology has significantly affected several fields of study including 
cell/cancer biology, drug delivery, and gene/drug screening.  Specifically, the integration 
of microfabrication, microfluidics, and cell cultivation technologies has revolutionized 
the way researchers approach fundamental biological topics.  Attempts to comprehend 
cellular complexities resulting from multiple signaling pathways and genetic expression 
profiles have forced the need to perform several experiments simultaneously.  This 
growing need to perform experiments in parallel in association with developing 
technologies such as genomic sequencing and combinatorial drug/gene compound 
screening has resulted in increased demand for miniaturized systems that can facilitate 
such experiments.   
Microfabrication and Microfluidics technologies provide unique opportunities to 
design, build, and conduct experiments on the micrometer scale (0.1 – 100 µm) [1-5].  
These technologies have the potential to expand the existing capabilities of biological and 
drug screening systems as they enable conventional assays to be conducted using an 
automated and high-throughput approach [6-7].  Cell cultivation (a key aspect of various 
biological and pharmacokinetic systems) has benefited the most from these technologies, 
since they provide new approaches to manipulate cells and their local microenvironments 
[8-9].  Cells in their native microenvironments are subjected to signals that vary both 
spatially and temporally (Figure 1-1).  Biological cues necessary for normal cell 
functioning such as growth factor gradients, cytokine releases, and protein secretion can 
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be controlled using miniaturization technology.  In addition, using these technologies, we 
can present cells with mechanical and biochemical stimuli similar to those found in the 
extracellular matrix (ECM) [8].  As an example, using microfabrication technology, we 
can precisely control the surface architecture and topography with which cells are 
cultivated and manipulated in vitro.  The opportunity to pattern cells and small 
biomolecules on culture substrates provide geometrical control over cell shape, size, and 
location [1, 8].  Temporal and spatial control on the cellular length-scales (10 – 100 µm) 
has been used in fundamental studies [10-13] ranging from subcellular [10] to the 
organismal [11] level.  For example, researchers have used these approaches in studies of 
cell division axis orientation [12] and geometric influence on cell survival and 
proliferation [13].   
 
 
Figure 1-1. Cells in their native microenvironment exist in three-dimensional tissue spaces and are 
subjected to cues from other cells, extracellular matrix components, and gradients of various biochemicals.  
This cellular microenvironment can be controlled using microfabrication technology.    
 
 
Micro-Environment 
Substrate (architecture, topography, etc.) 
Cell-Cell Cell-Substrate
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Aside from the traditional advantages conferred by miniaturization, the biggest 
potential very well lies in the physics of the microscale [3, 14-15].  Microfluidics is the 
study of fluid motions at the micron-scale [14-15].  By comprehending and leveraging 
microscale features such as a high surface area to volume ratio (SAV), microfluidics can 
be used to perform experiments not possible using standard techniques, allowing new 
functionality and experimental archetypes to emerge [14-16].  For example, different 
effects such as laminar flow, diffusion, fluidic resistance, and surface tension become 
dominant in microscale systems [15].  Laminar flows or low Reynolds number flows, in 
which mixing occurs mainly by diffusion can be used to effectively generate temporally 
stable gradients of small biomolecules, and thus, allow for a better representation of the 
in vivo cellular microenvironment [15].  Other microscale forces due to surface tension 
have been used to form and manipulate the transport of liquid droplets [17].  These liquid 
droplets can be used in a controlled manner to achieve functions such as biological 
sample concentrations, localized chemical reactions, and detection [18].  
Microfluidic systems comprising nozzles, pumps, reservoirs, channels, mixers, 
and valves have also been developed for use in a variety of applications including cell 
handling, drug dispensing/delivery, biochemical printing, and transport of various 
biomolecules.  Compared to conventional fluidic systems, microfluidic devices provide 
enhancement of analytical performance, favorable electric field scaling, low power 
requirement, and low reagent consumption [4, 6].  The ease of integrating electrodes 
along with the favorable scaling of electric fields in microenvironments creates 
opportunities to use electric field-induced forces such as dielectrophoresis (DEP) to move, 
separate, and position various bioparticles such as DNA, proteins, and biological cells 
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[19-22].  For instance, by using DEP and microfluidics, breast cancer cells were 
effectively separated from dilute blood by selective capture onto microelectrodes [19].  
Voldman et al also successfully demonstrated the trapping of mammalian cells using 
dielectrophoresis [20-22].  
The remaining sections in this chapter will provide a central review of the 
microfabrication technologies used for this thesis and their applications in cell biology 
research focusing on miniaturizing macro-scale cell cultivation systems to provide ease 
of adaptation for high-throughput screening as well as engineering the cellular 
microenvironment.  A brief background on epithelial biology and hepatitis B virus is 
provided and the chapter concludes with an introduction to the work done in this thesis 
pertaining to breast cancer research, liver biology, and hepatitis B viral replication studies.  
 
 
1.2 Microfabrication Technology 
Microfabrication is a manufacturing technology that uses different techniques to 
transfer geometric shapes or patterns with micron-scale dimensions to the surface of a 
substrate.  Microfabricated devices also known as Micro-electro-mechanical systems 
(MEMS) have existed for many years with several applications attaining commercial and 
scientific successes [23].  The merger of such technologies and biological systems, 
including cells, has resulted in the formation of a new field called biological micro-
electro-mechanical systems (BioMEMS).  In this field, the tools that have been 
traditionally developed for the microelectronics industry are applied to biological systems.  
Typical microfabrication processes include photolithography, surface or bulk 
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micromachining (wet and dry etching techniques), and soft lithography.  The most widely 
used technique is photolithography and it is usually the first step in many 
microfabrication processes.    
 
Photolithography: 
Photolithography (photo- “light” lithography “stone writing”) is a technique that 
uses ultraviolet light to create patterns on a substrate typically glass or silicon.  
Photolithography uses beams of light projected through a photomask (a glass or 
transparency sheet containing opaque and transparent regions to allow light to pass 
through in a defined pattern) to transfer patterns onto a substrate covered with a 
photosensitive material known as photoresist.   
Photoresist is an organic polymer such as epoxy resins that can change their 
chemical structure when exposed to ultraviolet light (UV).  There are two types of 
photoresist: positive and negative photoresist.  In positive photoresists, exposure to UV 
changes the chemical structure of the resist so that it becomes more soluble in developer.  
On the other hand, exposure to UV causes the negative photoresist to become 
polymerized making it insoluble in the developer.   During development, areas unaffected 
by the resist are either washed away in solution or remain on the substrate depending on 
the resist used leaving behind the desired pattern (Figure 1-2). The steps involved in 
photolithography include substrate cleaning, photoresist application, soft baking, mask 
alignment, ultraviolet light exposure, development, and hard baking [23].   
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Figure 1-2. Fabrication process flow for the photolithography process.  The photoresist material is 
deposited onto a substrate via spin coating and then exposed to UV through a photomask.  The photoresist 
areas affected by the UV light are processed in a developer solution leaving behind the desired patterns. 
 
Substrate cleaning is a very important step in the photolithographic process.  It 
helps to chemically remove contaminants such as particulates as well as traces of organic, 
ionic, and metallic impurities from the substrates.  It is often performed using organic 
solvents such as acetone, methanol, and isopropanol.  Piranha (a combination of sulfuric 
acid and hydrogen peroxide) can also be used as an alternative method to clean various 
Negative Photoresist 
Substrate 
Positive Photoresist 
Photoresist Coating 
Mask Alignment/UV Exposure 
Development 
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substrates and it is a powerful cleaning material for removing residual photoresist from 
the previous processing steps.  Following cleaning, the substrate is covered with the 
photoresist material by spin coating.  The spin coating is performed using a special 
coating machine that provides adequate control over spinning parameters such as speed, 
acceleration, and duration of coating.  This spinning process defines the thickness of the 
photoresist. 
Following the photoresist application, the photoresist-coated substrate is then 
“soft-baked”, i.e. it is placed on a hot plate with temperature settings ranging from 65ºC 
to 95ºC for a specified duration in order to solidify the adhesion of the photoresist to the 
substrate.  After the soft-baking process, the photoresist is then exposed to ultraviolet 
light via a photomask with predefined patterns.  This process is then followed by 
development in a solution that can interact with the chemically altered photoresist.  Once 
adequate development is achieved, a final hard baking step may be performed in order to 
harden the photoresist and improve the adhesion of the photoresist to the wafer surface. 
 
 
Soft Lithography: 
While photolithography has been essential for making small devices, it has some 
challenges that make it unsuitable for bio-based applications.  Conventional 
photolithography has disadvantages which include high costs associated with the 
photolithographic process (classified clean rooms, spinning machine, aligners, and UV 
exposure systems), as well as the chemically harsh conditions that are not suitable for 
biological systems.  Recently a new set of fabrication techniques have emerged using 
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polymeric materials such as polymethylmethacrylate (PMMA), polydimethylsiloxane 
(PDMS), and poly-para-xylylene (Parylene) that offer many advantages in BioMEMS 
applications when compared to silicon and other semi-conductor materials.  Some of the 
advantages include enhanced compatibility with biological systems, low temperature 
processing, increased mechanical strength, and lower cost of preparation [24-25].  Over 
the years, several polymer-based processing methods have been developed including 
micro-molding, embossing, casting, thick-resist lithography, stereolithography, and soft-
lithography [24-26].   
Soft lithography is the most common method used by most laboratories and was 
developed and characterized by George Whitesides [24-26].  Most of the soft lithographic 
processes are based on the use of soft elastomeric membranes to transfer patterns using 
micromolding.  Polydimethylsiloxane (PDMS) is the most commonly used elastomeric 
material in Microfluidics and Lab-on-a-chip applications.  PDMS micromolding is a 
common first step in the preparation of many polymer based MEMS devices.  As a 
fabrication tool, PDMS is very powerful because it can completely copy many patterns of 
interest down to the nanometer range.  In terms of packaging microfluidic devices, 
PDMS serves two purposes:  It can be a platform that allows for the integration of various 
microfluidic components, and it provides an interface between the mesoscale and 
microscale devices.  PDMS can house complex, three-dimensional fluidic structures 
molded into it, including reservoirs to deliver and receive fluid samples to and from 
tubing, syringes, flow channels, and other membranes [15]. 
PDMS-based devices offer many advantages over silicon, glass, or other materials 
for cell cultivation and other bio-related applications.  It is biocompatible (i.e. non-
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cytotoxic), autoclavable, optically transparent, thermally stable, highly gas permeable, 
and amenable to surface changes [15].  However, there are some disadvantages of PDMS 
such as high hydrophobicity, which makes it difficult to introduce water-based materials 
into devices.  In addition to gases, water vapor and organic solvents can also permeate 
PDMS, potentially causing unwanted evaporation and changes in solution osmolality [27-
28].   
The PDMS micromolding (Figure 1-3) process requires a previously fabricated 
master mold containing the pattern of interest (i.e. a photoresist template).  The PDMS 
prepolymer and curing agent (Dow Corning Sylgard 184) are prepared in a 10:1 ratio.  
The mixture is then poured onto a Petri dish containing the photoresist template and 
degassed in a vacuum dessicator to remove excess bubbles.  The curing process takes 
place in a convection oven with temperatures ranging from 60ºC to 100ºC for an 
appropriate duration in order to complete the polymerization process.  Once the cross-
linking process is completed, the PDMS is peeled from the mold, cut down to an 
appropriate size, and is then directly bonded to the surface of a substrate such as glass.   
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Figure 1-3. Schematic Representation of the PDMS Fabrication Process.  The PDMS prepolymer is mixed 
in a 10:1 ratio with the curing agent and poured over the photoresist template.  Polymerization occurs in a 
convective oven followed by release of the PDMS membrane with the newly defined patterns. 
 
Micropatterning: 
 Micropatterning is another powerful technique developed to create miniaturized 
patterns of biomaterials using soft lithography techniques.  Most micropatterning process 
require the use of PDMS as a stamp or stencil to mold and transfer patterns.  Techniques 
include replica molding, micro contact printing (µCP), microtransfer molding (µTM), 
and micro-molding in capillaries (Figure 1-4).  Replica molding is a process of direct 
duplication of patterns onto a substrate.  It uses materials with liquid precursors to 
directly copy patterns (e.g. shape, morphology, and structure) present on a PDMS 
template [24-25].   
Photoresist Template 
Mold Preparation 
Coating of Photoresist Mold 
Membrane Release 
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 Micro-contact printing is another method to transfer materials of interest from the 
PDMS stamp to a substrate.  Many studies using µCP routinely generate patterns of 
materials such as proteins on surfaces coated with gold using self-assembled monolayers 
(SAMs) of alkanethiols.  The PDMS stamp is “inked” with a solution of an alkanethiol 
and brought in direct contact with a gold substrate.  The alkanethiol is transferred to the 
gold substrate only in the regions where the PDMS stamp contacts the substrate.  Since 
SAMs presenting alkanethiols are able to resist protein adsorption, the patterned 
deposition of SAMs on surfaces can be used in a way to control protein or cell adhesion 
[24-25, 29-30].  In addition to µCP, another powerful technique for micropatterning is 
micromolding in capillaries (MIMIC).  This technique uses a network of microchannels 
to deliver materials to desired regions of a substrate.  The technique is based on the 
spontaneous filling of microchannels formed between a PDMS stamp having recessed 
relief features on its surface and a flat substrate. The PDMS microchannels are filled by 
capillary action with a fluid that may be a liquid precursor or suspension of materials to 
be formed.  The PDMS is then removed once the fluid material is crystallized and the 
microstructures remaining on the surface are complementary to that present in the mold. 
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Figure 1-4.  Schematic representation of micromolding processes using PDMS (Replica molding, 
microtransfer molding, and microcontact printing) 
 
Microtransfer molding is a relatively simple and alternative method for replicating 
the 3D topography of a PDMS membrane with resolution at the micron-scale.  In 
microtransfer molding, a drop of liquid prepolymer is applied to the patterned surface of 
a PDMS mold and the excess liquid is removed by scraping with a flat block made of 
PDMS or glass.  The filled mold is then placed in contact with a substrate and either 
Replica Molding 
Substrate Substrate 
Microtransfer Molding (µTM) 
Substrate Substrate 
Weight 
Substrate Substrate 
Microcontact Printing (µCP) 
PDMS Mold 
Treated PDMS Stamp 
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heated or kept at room temperature until the polymerization is completed.  After the 
liquid pre-polymer is cured, the mold is peeled away carefully to leave behind the 
patterns on the substrate [24-25, 29].  One of the aims of this thesis was to develop new 
techniques to create micropatterns of Matrigel, a protein based hydrogel used for 3D cell 
cultivation.  In order to do this, we used techniques such as microtransfer molding and 
newly developed techniques such as dual layer dry lift-off.  Details regarding this process 
will be described in chapters 2 and 3. 
 
 
1.3 Biological Applications of Microfabrication Technology 
Over the past few years, many microfabricated devices with applications in 
molecular biology and biochemistry have been realized [31-53].  For cell-based 
microsystems, some researchers take the approach of simply micro-manufacturing 
existing conventional laboratory techniques [41-46].  For example biological techniques 
such as polymerase chain reaction (PCR) [41], Enzyme linked Immunosorbent Assay 
(ELISA) [44] and fluorescent activated cell sorting (FACS) [46] have been successfully 
miniaturized.  Other researchers exploit the benefits of the small length scales utilizing 
laminar flow properties and electric fields to manipulate biological samples [47-53].  
Most of these cell-based microdevices are built under the umbrella of a lab-on-a-chip or 
micro-total-analysis system (µTAS) framework that seeks to integrate various steps of 
macroscale laboratory techniques on a single platform [4].  Published work in this area 
spans from devices for examining subcellular components, such as DNA and proteins, to 
devices involved in cell biology [31-53]. 
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Microsystem devices enabling cell-based assays covering all the steps from cell 
cultivation, through selection and treatment to downstream biochemical analysis have 
also been demonstrated [31-57].  Several groups have developed microfluidic systems to 
demonstrate the importance and physiological relevance of micro scale cell culture in 
basic cellular and molecular biology as well as cancer biology.  Besides addressing the 
biocompatibility and adequate nutrient supply issue in microfluidic devices, these works 
were also successful in maintaining the physicochemical and physiological environment 
with which cells are manipulated in vitro.  As an example, Walters et al observed in vivo 
growth rates when mouse embryonic stem cells were cultured in elastomeric 
microchannels [54].  Microfluidic devices that incorporate continuous perfusion for long-
term monitoring of mammary cells [55] and muscle cells [56] have also been reported.  
Shackman et al also reported a microfluidic cell culture device with an on-line immuno 
assay [57].  More recently, we have also demonstrated the capability to perform 
biological assays such as DNA transfection or viral infection of cells using 
microfabricated channels [32]. 
Microfabrication also provides a promising technology for manipulating and 
patterning essential ECM components with micron-scale resolution [58-62].  The ability 
to control cell organization within the matrix environment would enable reproducible 
control over the cellular microenvironment.  Researchers have provided opportunities to 
understand how the biochemical and mechanical interactions of cells with the essential 
matrix components contribute to changes in cellular behavior [59].  For example, Chen et 
al demonstrated that by micropatterning adhesive ECM islands and altering the spacing 
of cell adhesion islands, it is possible to control the extent of cell spreading, shape, 
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growth, and survival [58-59].   Bhatia et al recently demonstrated the capability to 
encapsulate cells within three-dimensional matrices in order to mimic the in vivo cell-
tissue organization by developing 3D hepatic tissue culture systems using 
photopolymerizable hydrogels filled in microfluidic devices [60-61].  Khademhosseini et 
al also developed a new generation of hydrogels with spatially oriented properties using 
microfluidic channels and photocrosslinkable polymers in order to better direct cell 
behavior such as migration, adhesion, and differentiation [62].   
In recent years, new generation of miniaturization technologies are being 
developed to examine various disease states and pathologies such as cancer, hepatitis, and 
diabetes [63-67].  Cancer biology being a prevalent research field has seen the most 
benefit of microfabricated platforms.  Researchers have demonstrated the ability to detect 
cancer cells using a variety of techniques from micropatterned nanoparticles 
immunolinked to target specific cancer cells [66-67] to cell sorting devices that separate 
cancer cells based on changes in physical properties [67].  Others have focused on 
facilitating cancer drug screening by developing technologies to probe cancer cells in 
parallel [68].  Our work in this arena focused on the development of miniaturized 
cultivation devices that recreates the native cancer microenvironment in a platform that 
also supports throughput experimentation [31].  The long-term consequence of these 
endeavors would be significant improvements in developing balanced approaches to 
therapy as well as to improvements in cancer diagnosis. 
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1.4 Epithelial Biology and Cancer 
Epithelial cells are closely packed cells that are arranged in continuous sheets 
composed of one or more layers of organized, polar cells circumscribed by a basement 
membrane made up of extracellular matrix (ECM) proteins [69-73].  This basement 
membrane provides structural support and functional information for epithelial cell-tissue 
development [75-76].  This organization is essential for epithelial cells to perform various 
functions.  For example, these cells can collectively serve as selective barriers to protect 
the underlying tissue from the outside [70-72].  The tight junctions between individual 
cells play an important role in the barrier function of these cells [70].  Another major 
function of these cells includes regulation of body homeostasis via secretion of various 
regulatory proteins, metabolic agents, and hormones [71-72]. Other functions include 
absorption, sensing, and contraction [71-72].  
Over the years, epithelial cells have become an important focus of cancer related 
research [73-74]. The most common forms of cancer, called carcinomas, originate from 
epithelial cells (e.g. breast cancer, liver cancer, skin cancer, etc.) and account for the 
majority of adult cancers.  Like all cancers, they result from a breakdown in the normally 
tight controls over cell proliferation, organization, and survival [75-76].  Epithelial cell 
behavior including growth, polarity, adhesion, and survival are regulated in part by the 
signals that arise from either communication with neighboring cells or the extracellular 
matrix (ECM) [76].  These signals are lost in cancer cells [77].  This loss of 
communication is typically accompanied by disruption of the organization of the cells 
[76-77].  This loss of normal cell structure is a trademark of cancer, and a prerequisite to 
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metastasis, a process whereby, the cells can then relocate to form secondary cancers in 
other organs [78]. 
Epithelial cell cultivation has played a fundamental role in understanding the 
processes involved in cancer initiation and progression [79-82].  This unique capability to 
isolate and grow cells ex vivo has led to the development of new technologies, including 
drug screening procedures and large scale protein production [87].  One commonly used 
experimental setting is a two-dimensional (2D) model or monolayer system, in which 
cells are plated onto surface-treated glass or plastic Petri dishes [79, 85].  These 
monolayer culture methods make it easy to control single cell populations and simplify 
the manipulation of large quantities of cells [79].   
Conventional tissue culture is typically based on growing mammalian cells that 
have been selected for growth under optimal conditions provided in the culture.  Some 
cells that survive under these conditions are typically immortalized cells that have genetic 
modifications that allow them to be cultivated in vitro indefinitely, something that cannot 
be done with primary cells [88].  Consequently, using them to understand in vivo cell 
behavior has limits.  This limitation is especially apparent when trying to create 
functional tissues ex vivo, such as a liver.   For example, liver cells have been shown to 
rapidly lose normal morphology and differentiated functions in monolayer systems [89]. 
With regards to cancer research, a significant drawback of 2D culture systems is 
that the culture conditions used to propagate cells create an environment that differs 
considerably from the normal tissue environment.  Cells integrate many external cues 
(chemical and physical), especially those that arise from other cell types and various 
ECM components.  These external probes are missing in 2D cultures and make it difficult 
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to study differences between normal and cancer cells.  For example, when normal 
epithelial cells are grown in monolayers, they exhibit highly plastic behavior and express 
many characteristics displayed by tumor cells [79].  In addition, cells have been shown to 
respond differently to chemotherapeutic agents in 3D culture conditions compared to 2D 
[90].  Consequently, researchers have shifted to three-dimensional (3D) cell culture 
systems that provide a more physiologically relevant setting for studying epithelial 
morphogenesis and carcinogenesis.   
Epithelial cells lining glandular structures such as those found in the breast exist 
in 3D microenvironments within the tissues of the body [79].  Recent studies have shown 
that recreating this 3D context for cells in vitro is important for the retention of cell-tissue 
specific functions [79-80, 90-92].  Mina Bissell and colleagues have pioneered in vitro 
3D epithelial culture models that allow individual epithelial cells to undergo a series of 
morphogenetic events that lead to the formation of tissue-like masses resembling those 
found in vivo.  For example, they have demonstrated the formation of mammary acini 
(hollow spherical masses found in vivo) by placing single mammary epithelial cells in or 
on top of a layer of reconstituted basement membrane complex (known commercially as 
Matrigel) [93]. 
Matrigel is a very popular biomatrix hydrogel derived from the Engelbreth-Holm-
Swarm (EHS) tumor for 3D cell cultures [94].  It contains many essential components of 
the ECM such as collagen, laminin, entactin, and other important growth factors [94].  
The 3D environment created by Matrigel helps to mediate the physiological responses 
regulating normal cell growth, differentiation, survival, migration, and tissue organization 
[77, 95].  Interestingly with regards to cancer research, culturing cells in Matrigel has 
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also revealed various invasive properties of cancer cells, such as invasion through the 
basement membrane [95].  The use of Matrigel in cultures also has some disadvantages.  
For example, the composition of Matrigel remains poorly characterized due to variability 
that exists from lot to lot [96].  The heterogeneity of Matrigel can thus make it difficult to 
interpret experimental results.  Although, a more purified version of Matrigel exists in the 
form of growth factor reduced Matrigel, the purification process does not entirely remove 
all endogenous growth factors present, which may still lead to variability in experiments. 
  
 
 
Figure 1-5.  3D Morphogenesis of Mammary Epithelial Cells on Matrigel.  Single mammary epithelial 
cells form mammary acini (hollow spherical masses found in vivo) when placed in or on top of a layer of 
reconstituted basement membrane complex (known commercially as Matrigel) [Adapted from Joan 
Brugge]. 
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The development of in vitro 3D tissue models is also beneficial for studies that are 
based on human samples as the most physiologically relevant model.  Although animal 
models can capture some important aspects of human responses, they fail in cases where 
pathogens are species specific (e.g. hepatitis B and C) [97].  Moreover, a leading cause 
for the failure of new drugs in clinical trials is organ toxicity that was not predicted by 
animal models or other in vitro models [98].  Therefore, the value of experimental models 
using 3D tissue culture is that researchers can now study the molecular processes 
necessary for normal epithelial development and maintenance while manipulating them 
to reveal how cancer genes/drugs affect this process. 
 
1.5 Hepatitis B Virus and Liver Cancer 
The human hepatitis B virus (HBV) belongs to a family of DNA viruses known as 
Hepadnaviridae, a group of viruses that primarily infect the livers of their host organism 
[99].  HBV is also a major contributor to liver disease:  chronic infections of the liver 
with HBV have been linked to liver cirrhosis, as well as the development of primary liver 
cancer, hepatocellular carcinomas (HCC) [98, 100].  HBV is transmitted both sexually 
and parenterally, and a recent estimate by the World Health Organization (WHO) shows 
that 350 million people are chronically infected worldwide and approximately 25% of 
those chronically infected with HBV will eventually die from chronic liver disease [101].  
Therefore, it is important to understand the process by which persistent HBV infection is 
maintained and linked to the development of liver cancer. 
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Like other hepadnaviruses, HBV has a very narrow host range, only naturally 
infecting humans, and experimentally infecting other selected animals [102].  How 
chronic HBV infections predispose individuals to HCC development is currently 
unknown, but likely involves a complex interplay between host liver cells and viral 
factors such as viral load, genotype, and genetic divergence due to mutations [99, 103].  
One approach to studying HBV-associated liver cancer is to understand the mechanism of 
HBV replication and to identify viral genetic factors associated with liver pathogenesis. 
HBV particle consists of an outer lipid envelope and a central portion composed 
of viral proteins Figure 1-6.   HBV contains a partially double-stranded DNA genome 
that is translocated to the cell nucleus, where it is converted into a covalently-closed 
circular DNA form, from which viral mRNAs are transcribed [100].  One of these viral 
transcripts, the pregenomic RNA, serves as a template for replication.  The pregenomic 
transcript in association with viral polymerase/reverse transcriptase is packaged into 
nucleocapsids that can then be enveloped and secreted from cells [100].   
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Figure 1-6.  HBV Molecule Adapted From James A. Perkins.  HBV particle consists of an outer lipid 
envelope and a central portion composed of viral proteins. 
 
 
Several models have been developed to study HBV including animal models, 
established cell lines, and primary hepatocytes [104-105].  Important processes pertaining 
to HBV infection and replication have been revealed by studying related hepadnaviruses, 
such as the duck hepatitis B virus (DHBV) [106], and the woodchuck hepatitis virus 
(WHV) [107].  However, many important differences exist among human HBV and 
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animal hepadnaviruses.  Human cell lines such as human hepatoblastoma cells (or HepG2) 
have also been established for introducing viral DNA into liver-derived human cell lines.  
However, these cell lines have questionable biological relevance since they display 
abnormal levels of liver functions [108].  Therefore, there is a need for novel in vitro 
cultivation models that can support the use of primary human cells as the most 
physiologically relevant system for studying HBV.   
Novel in vitro infection models are essential for the analysis of the first steps of 
the viral life cycle, including attachment, entry and uncoating, and in particular for 
studies of the underlying molecular interactions between viral particles and the target cell.  
In vitro infection models should take into consideration the species specificity and cell 
tropism of the virus but also, the condition of sustained differentiation of target liver cells 
for efficient in vitro infections.  In this thesis we present novel in vitro models for HBV 
replication studies based on primary hepatocyte cultures, in which target cells for HBV 
can be maintained in a differentiated state during experiments. 
 
1.6 High-Throughput Screening Systems 
Cancer researchers have made enormous progress in recent years in identifying 
important genetic targets that are intimately related to cancer initiation and progression 
[109-110].  It is also anticipated that more drugs that target cancer-specific molecules will 
be developed, which are more effective in eliminating cancer cells, and cause fewer side 
effects to patient.  However, progress in the field of anti-cancer drug discovery has been 
disappointing, and we still have a long way to go in treating leading cancers such as 
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breast, liver, lung, prostate, and colon cancer.  A major challenge facing this field is the 
lack of reliable tissue/tumor model systems for drug screening and evaluation [111].   
Drug screening strategies are needed that can rapidly exploit various target 
compounds associated with the complex gene expression changes that characterize 
various diseases such as cancer [112].  The use of high-throughput screening (HTS) 
platforms to perturb cellular disease models is an important aspect of target drug 
discovery [113-114].  HTS systems provide an automated approach to preparing, adding 
reagent, mixing, incubating, and analyzing many plates simultaneously [114].  It is an 
integrated system consisting of one or more robotic devices for liquid handling and 
transportation [114]. 
In order for cell-based models to be useful in HTS systems, these cellular assays 
must be able to accurately model critical features of the disease of interest [115-116].  
Moreover, these cell-based models should promote characteristic cellular activities such 
as differentiation, proliferation, migration and invasion, metabolism, viral infection, 
signaling, apoptosis, and other biological processes.  In addition to meeting physiological 
requirements for disease models, these systems should possess important attributes 
required for HTS such as scalability and potential to analyze a large number of genes and 
biochemical compounds.  In addition, these systems should also permit isolation and 
separation of cells of interest from the general population [115].   
One possible way to address the requirements of combining high-throughput 
experimentation and to control cell microenvironment is through the use of 
miniaturization technology [111].  Microfabrication technology creates the unique 
capability to miniaturize assays so that they can be easily integrated in a HTS system, 
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with the potential of performing cost effective tests for many input and output parameters 
[111].  For example, Khetani et al demonstrated the use of microfabricated elastomeric 
microwells in standard multi-well plate format for use in automated screening systems 
[108].  Moreover, such technology could be potentially used to control cell interaction 
with its environment at scales which are relevant for cell biology [83, 87].  The merger of 
such technologies and biological systems, including cells, could be used to control and 
analyze cellular responses to drugs and other biochemical compounds. 
The overall goal of this thesis is combine novel microfabrication and epithelial 
cell cultivation techniques in order to develop miniaturized technologies that transcend 
the limitations of conventional macroscopic two-dimensional culture systems, by 
approaching the native environment of cells in vivo through technologies that allow direct 
screening of cultivated cells with drugs and targeted therapeutics in an appropriate 
context.  As can be seen in Figure 1-7, the merger of these technologies requires a 
multidisciplinary approach.  The platforms and techniques developed in this thesis have 
many potential applications which will prove valuable for many fields. 
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Figure 1-7.  Technologies and Disciplines Relating to Building Miniaturized Devices for Epithelial 
Cultures and Cell-based Screening 
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CHAPTER 2. MICROPATTERNED MATRIGEL FOR THREE-
DIMENSIONAL EPITHELIAL CULTURES 
2.1 Introduction 
Cell culture studies are often performed on synthetic substrates such as glass or 
plastic that forces cells to adjust to artificially flat and rigid surfaces.  Although these two 
dimensional (2D) in vitro cell culture systems provide a convenient and rapid means of 
biochemical analysis, they lack proper cues found in tissue microenvironments in vivo; 
therefore, limiting the use of these studies for tissue-specific functions and structural 
signals.  In contrast, three dimensional (3D) cell culture models allow studies into 
biological processes in a setting that more closely resembles in vivo environments and 
thus provides a more physiological context.  3D model systems are currently being used 
to understand the signals that regulate normal tissue functions and how these functions 
are disrupted in disease states such as cancer [1, 2]. 
The mammary gland provides an ideal model for understanding relationship 
between normal tissue function and architecture.   Mammary epithelial cells exist in 3D 
space and form a 3D architecture known as an acinus in which milk is secreted into a 
central lumen by a single continuous layer of epithelial cells [3-6].  This structure is 
encased by a layer of myoepithelial cells and a basement membrane composed of 
extracellular matrix (ECM) proteins that provide structural support and functional 
information.  This general architecture and function can be recapitulated in vitro by 
culturing mammary epithelial cells completely surrounded by exogenous matrix.  
Epithelial cells grown in 3D cultures form cyst-like spheroids with a hollow lumen, 
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establish their own basement membrane, have tight control of cell growth, and form 
apicobasal polarity [3-6]. 
Cultured epithelial cells respond to appropriate matrix proteins that is similar to 
the composition of matrix found in the tissue of origin; for example, the basement 
membrane surrounding mammary epithelial cells is composed of matrix proteins such as 
laminin and collagen.  One of the most commonly used mixtures of exogenous matrix is 
derived from the Engelbreth-Holm-Swarm (EHS) tumor that is commercially available as 
MatrigelTM [6].  Matrigel is a biomatrix hydrogel that contains many essential 
components of the ECM such as collagen, laminin, entactin, and other important growth 
factors.  When a single human immortalized mammary epithelial cell (MCF-10A) is 
placed in or on top of a layer of Matrigel (approximately 1 mm thick) and overlayed with 
additional Matrigel [7], cells undergo a morphogenetic program that culminates in the 
formation of acini-like structures highly reminiscent of normal epithelial architecture [8]. 
Studies in 3D cultures have also provided model systems to study how cancer 
genes disrupt the biological interactions of individual cells with their immediate 
surroundings and have become valuable tools for understanding cancer initiation and 
progression [9-11].  For example, filling the lumen with cells is a prominent feature of 
early epithelial cancers that remains poorly understood [9].  3D culture studies have also 
uncovered key apoptotic regulators that are involved in the formation of the luminal 
space that are targeted by oncogenes to induce luminal filling [9-10].  Moreover, known 
cancer genes, when examined in 3D systems, give rise to a number of phenotypes that 
resemble pathological features observed in epithelial cancers in vivo, including 
phenotypes such as invasion through basement membrane [11].  In addition, cells have 
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been shown to respond differently to chemotherapeutic agents in 3D culture conditions 
compared to 2D [4, 12].  Thus, 3D culture can not only recapitulate normal epithelial 
structure and function but can also allow for more detailed understanding of tissue 
dysfunction in disease states and may offer a more realistic milieu for modeling 
therapeutic intervention. 
However, conventional 3D models (Figure 2-1) have some challenges that 
warrant consideration; cells are randomly distributed within the Matrigel, resulting in 
overlapping cells that may grow at different rates, thus making individual cell analysis 
difficult.  In addition, Matrigel and other reagents used for the 3D studies are very 
expensive, making these systems less amenable to large scale cellular studies.  Well-
defined micropatterns of Matrigel, in which single cells can be cultured into 3D acini can 
address those issues of current 3D culture systems.  They can enable high-throughput 
analysis by providing control of cell distribution and growth rate (Figure 2-1).  In 
addition, the spatial organization of cells within the patterned environment can be 
controlled using this technology, thus enabling reproducible control over the cellular 
microenvironment. 
There have been attempts to create microfabricated platforms for culturing cells in 
3D conditions [5, 13, 35-39].  Previous demonstrations of microscale 3D cell systems 
include works by Sangeeta Bhatia, who demonstrated the encapsulation of liver cells 
within photopolymerizable hydrogels in order to create an organized 3D context for 
hepatocytes [35-36].  More recently, Ali Khademhosseini developed a microfabricated 
platform made of poly (ethylene glycol) microwell arrays to provide a 3D framework for 
embryonic stem cell proliferation and differentiation [37-39].  These works were 
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successful in controlling the spatial localization of cells within patterned 3D 
microenvironments and demonstrated the utilization of such systems for high-throughput 
experimentation. 
Our work in building microscale 3D culture platforms takes a different approach 
in that instead of just coating surfaces with thin layers of synthetic matrices, we take an 
approach that fully recapitulates standard 3D culture assays, where cells are totally 
embedded or overlayed with ECM to mimic the 3D microenvironment necessary to 
establish tissue-specific functions as well as mechanical and structural signals [14].  In 
this study, we present general strategies for creating bulk micropatterns (0.001~1 mm3) of 
Matrigel that can be used as a platform for 3D epithelial culture of normal and cancer 
cells.  Diverse soft lithography techniques and surface modification methods were 
investigated to achieve deformation free-patterning of Matrigel.  Each bulk micropattern 
is to serve as housing for single epithelial cells during 3D cell culture.  Moreover, we 
show comparable results between culturing normal and cancer cells in standard 3D 
culture to cells cultured using our novel 3D microfabricated platform. We believe that 
this work will enable the development of miniaturized 3D epithelial cell culture and 
screening platforms with a wide variety of applications in cancer biology, tissue 
engineering, as well as drug/gene screening technology. 
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Figure 2-1.  A schematic diagram comparing conventional 3D cell culture system to a microfabricated 3D 
culture platform.  In conventional 3D cultures, cells are randomly distributed within the Matrigel, resulting 
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in overlapping cells that may grow at different rates, thus making individual analysis difficult.  In addition, 
Matrigel and other reagents used are very expensive making these systems less amenable to large scale 
cellular studies.  In a microfabricated setting, we can achieve an organized array of cells on patterned 
Matrigel that can be used for cell-based screening of various biochemical reagents and drugs. 
 
 
2.2 Materials and Methods 
Fabrication of Poly (dimethylsiloxane) (PDMS) Mold/Mask 
 The fabrication process for creating the PDMS mold and mask membranes are 
shown schematically in Figure 2-2.  The photomask used for our processes contained 
simply arrays of circles and squares with dimensions ranging from 100 to 800 μm, based 
on the size range of developed mammary acini (~20-100) [20, 40].  Negative photoresist, 
SU-8 2035 (Microchem Corporation) was spun onto a 2 inch x 2 inch borosilicate glass 
substrate at an initial speed of 500 rpm at 100 rpm/s for 10 seconds followed by 
additional spinning at 1000 rpm – 300 rpm/s for 30 seconds.  Soft baking of photoresist 
was achieved on hot plate at 65ºC for 5 minutes and at 95ºC for 20 minutes.  UV 
exposure through a chrome mask was performed with approximately 500 mJ/cm2 of 
energy.  Post-exposure baking on hot plate at 65ºC for 1 minute and at 95ºC for 10 
minutes was followed by development in SU-8 developer (Microchem Corporation) and 
cleaning in isopropanol for five minutes.  This process yielded circular posts with heights 
of approximately 200 μm. 
 Depending on the patterning technique employed, the previously fabricated SU-8 
master was either directly placed in a 3-inch plastic dish for standard PDMS replica 
molding or PDMS was spun over SU-8 master at controlled speeds.  For PDMS replica 
molding, PDMS (Sylgard 184, Dow Corning Corporation) was prepared in a 10:1 
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(prepolymer: curing agent) ratio, cast as desired, degassed to remove air bubbles and then 
cured at 80ºC in convective oven for 1 hour.  After cooling at room temperature, 
membrane was peeled off mold, cut down to size resulting in PDMS membranes with 
microwells defined by the SU-8 dimension (Figure 2-2a).  The second fabrication method 
involved creating PDMS membranes with through-holes and was previously described by 
Jackman et al [15].  PDMS was spun at an initial speed of 750 rpm at 100 rpm/s for 10 
seconds to ensure that the surface of the mold was completely covered, followed by 
additional spinning at 1500 rpm – 300 rpm/s for 50 seconds such that the height of the 
resulting layer is lower than the height of the SU-8 mold.  After curing in the convective 
oven (80ºC) for 2 hours, the membrane was gently peeled off the mold yielding through-
hole membrane with variable thickness ranging from 80 to 120 μm.  These through-hole 
membranes retained the unique interfacial property of PDMS and stuck reversibly to 
itself and glass.  A small droplet of isopropanol was used to prevent self-adhesion of 
membranes and to aide membrane handling. 
 
Matrigel Handling and Patterning 
 Modified Microtransfer Molding 
Growth factor reduced Matrigel (BD Biosciences) was removed from frozen 
storage (-20ºC) and placed on ice bath to thaw until ready for use.  The gelation of 
Matrigel is very rapid at room temperature, therefore, pre-chilled pipettes and cold plates 
were used during patterning to delay solidification.  Two possible arrangements of 
Matrigel patterns can be achieved as shown in Figure 1b.  Free-standing patterns of 
Matrigel can be made on a flat substrate or buried patterns of Matrigel can be achieved in 
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PDMS molds with microwells.  To generate free-standing micropatterns of Matrigel, we 
used a method similar to microtransfer molding (μTM) as shown in Figure 2-2a.  Several 
surface modification techniques for the PDMS membrane were investigated to prevent 
distortions and/or deformations of the Matrigel structures during patterning and 
membrane release.  The first method involved treatment of the PDMS membranes by 
adsorbing monolayers of bovine serum albumin (BSA) [16-17].  PDMS membranes were 
immersed in Petri dishes containing 10% BSA in phosphate buffered saline (PBS) 
solution.  The samples were allowed to soak for about 1 hour, rinsed with fresh PBS, and 
then allowed to dry at room temperature.  The second method involved a 30 second 
oxygen plasma treatment of PDMS membranes in the Harrick Plasma PDC 32-G System 
(Harrick Plasma), followed by treatment with poly (2-hydroxyethylmethacrylate) (poly-
HEMA).  The samples were either allowed to soak in a dish containing 10% poly-HEMA 
(6mg/ml in ethanol) or the poly-HEMA was directly spun onto the PDMS membranes 
and allowed to dry at room temperature.   
To create the Matrigel patterns, a small droplet of Matrigel in the liquid phase was 
placed gently on a glass slide (taking care not to generate bubbles).  The treated PDMS 
stamp was then placed directly over the Matrigel droplet such that the Matrigel was 
trapped within the microwells.  A small force was then applied to ensure that excess 
Matrigel was removed from the slides.  Complete gelation of Matrigel was achieved by 
placing the device in an incubator at 37ºC for approximately 15 minutes.  The membrane 
was then gently peeled off the glass substrate to release Matrigel islands defined by the 
microwell dimensions.  Buried patterns of Matrigel were also produced using this method.  
Instead of removing the PDMS membrane, the glass slide was gently slid over the top of 
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the membrane to remove excess Matrigel leaving behind patterns of Matrigel trapped in 
microwells.  Matrigel patterns were placed in a Petri dish and stored in a humidified 
incubator until ready for use. 
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Figure 2-2. Fabrication process flow for microtransfer molding and dry lift-off technique and pictures of 
SU-8 mold, PDMS through-hole membrane, and Matrigel micropatterns on glass substrate. 
 
 
Dual layer Dry Lift-Off Technique 
 The second method used for patterning Matrigel was based on a so-called dry lift-
off technique previously described by Jackman et al [15].  Dry lift-off technique is 
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similar to the conventional lift-off technique used for metal patterning in microelectronics 
and MEMS industry.  It involves the fabrication of PDMS membranes with through-holes 
that can serve as a masking layer during the patterning of proteins and biological 
molecules.  Through-hole PDMS membranes were fabricated as described in Section 2.2 
(Fabrication of PDMS Mold/Mask) and cut down to size.  The flat sides of the 
membranes were brought directly in contact with the glass substrate.  Oxygen plasma 
treatment and p-HEMA coating of the membranes were again performed to minimize the 
surface energy of the membranes and to increase the wettability of the surfaces.  There 
are two strategies for patterning using the dry lift-off technique (Figure 2-2b):  The single 
layer technique involved a similar patterning technique as μTM, where a small droplet of 
liquid Matrigel was placed directly over the membrane.  Excess Matrigel was removed 
using a glass slide and Matrigel was gelated in an incubator at 37ºC.  Following 
solidification of the Matrigel, the membrane was gently lifted off the substrate, leaving 
behind the Matrigel patterns.  The other technique involved the use of two congruent 
layers of through-hole membranes stacked together.  This dual-layer dry lift-off method 
allowed us to selectively pattern both Matrigel and poly-HEMA on a single substrate.  
First, we coated the bottom layer with poly-HEMA and placed the uncoated flat side on a 
glass slide and allowed it to adhere firmly to the substrate. This was followed by 
alignment with a plasma treated membrane over the bottom layer.  Once adequate 
alignment was achieved, as visualized under the microscope, a Matrigel droplet was then 
placed over the top layer, filling both wells; followed by gelation in the incubator.  The 
top membrane was then gently lifted off the substrate, leaving behind patterns of Matrigel 
partially buried in the bottom PDMS membrane with poly-HEMA in between.  Matrigel 
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patterns were placed in a Petri dish and stored in a humidified incubator until ready for 
use. 
 
3D Culture and Morphogenesis Assay 
 Human immortalized mammary epithelial (MCF-10A) cells and human breast 
adenocarcinoma (MDA-MB-231) cell lines were obtained from the American Type 
Culture Collection (Manassas, VA) and maintained on standard tissue culture dishes in 
5% CO2 humidified incubator at 37ºC.  The MCF-10A growth medium was composed of 
DMEM/F12 (Invitrogen, Carlsbad, CA) supplemented with 5% donor horse serum, 20 ng 
of epidermal growth factor (EGF)/ml (Peprotech, Rocky Hill, NJ), 10 μg of insulin/ml 
(Sigma, St. Louis, MO), 1 ng of cholera toxin/ml (Sigma), 100 μg/ml hydrocortisone 
(Sigma), 50 U/ml penicillin, and 50 μg/ml of streptomycin (Invitrogen) [9, 41].  MDA-
MB-231 cells were grown in DMEM supplemented with 10% FCS.  Following passage, 
cells were trypsinized and resuspended in growth medium containing 2% Matrigel and 
5ng/ml EGF.  These conditions are sufficient to promote the development of these cells 
into individual polarized acini structures [41].  For the standard 3D culture controls, cells 
were seeded at a density of 5000 cells/ml in an 8-well chamber containing an underlying 
approximately 1 mm thick bed of Matrigel as previously described [9].  Single cell 
placement on the Matrigel patterns was accomplished by controlling the cell seeding 
density.  The concentration of cells used is determined by the number of Matrigel 
patterns available.  We used approximately twice the number of Matrigel wells as the cell 
seeding density.  For example, in our culture chamber of 24 x 24 (400 μm diameter) 
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Matrigel microarrays, we seeded with approximately 1000 cells.  Assay medium 
containing 2% Matrigel was replaced every 4 days during the cell culture.   
 
Immunofluorescence and Image Acquisition 
 The morphology of the cells was observed using phase contrast microscopy and 
confocal microscopy.  Mammary acini were prepared as previously described [8-9].  
Briefly, MCF-10A acini were fixed in 4% formalin (10% formalin (Sigma) diluted in 1X 
PBS, pH 7.4) for 30 minutes at room temperature.  Fixed structures were washed with 
PBS-glycine (130mM NaCl, 7mM Na2HPO4, 100mM glycine) three times for 10 minutes 
each time.  The structures were then blocked in IF buffer (130 mM NaCl, 7 mM 
Na2HPO4, 3.5 mM NaH2PO4, 7.7 mM NaN3, 0.1% bovine serum albumin, 0.2% Triton 
X-100, 0.05% Tween 20) plus 10% goat serum for 1 hour at room temperature.  This was 
followed by a secondary block with IF buffer containing 10% goat serum and 20 μg of 
goat anti-mouse F(ab’)2/ml for 40 minutes.  Primary antibodies were diluted in secondary 
blocking buffer, followed by incubation overnight at 4ºC.  Structures were washed three 
times in IF buffer for 20 minutes each.  Anti-mouse or anti-rabbit secondary antibodies 
coupled with Alexa fluor dyes (Molecular Probes) were diluted in IF buffer containing 
10% goat serum, followed by incubation for 60 minutes.  After washing three times with 
IF buffer (20 minutes each), structures were incubated with 5 μM Topro-3 Iodide 
(Molecular Probes) and 0.5 ng of DAPI (4’, 6’ –diamidino-2-phenylindole; Sigma)/ml.  
A final rinse with IF for 5 minutes at room temperature was followed by mounting with 
the anti-fade prolong (Molecular Probes) and allowed to dry at room temperature.  
Confocal analysis was performed by using the Leica TCS SP2 AOBS confocal system.  
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Images were generated by using Leica software, converted to Tiff format and arranged 
using Adobe Photoshop 7.0.   
 
2.3 Results 
PDMS Membrane Treatment and Matrigel Patterning via Microtransfer Molding 
 PDMS membranes with microwells and microchannels were fabricated using 
standard PDMS replica molding.  In preparation for the microtransfer molding, the 
surfaces of the PDMS molds were treated with oxygen plasma in order to increase the 
wetting properties of the membrane and to allow us to create well defined patterns of 
Matrigel using these membranes.  Figure 2-3 shows liquid Matrigel on treated and 
untreated PDMS microwells.  Without surface modification of the membranes, patterns 
were often subject to bubble generation and partial well filling, however, oxygen plasma 
treatment of these membranes minimized these issues and it was possible to achieve more  
Figure 2-3.  Surface modification of PDMS membranes using oxygen plasma treatment.  Plasma treatment 
of PDMS membranes increases the wettability of the surfaces and reduces issues such as partial filling of 
microwells or bubble generation. (a,b) presence of bubbles in microwells and partially filled wells. (c) 
plasma treated PDMS had all filled wells with very little bubbles present. Scale bars: 100 μm 
 
a) b) c) 
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than 80% of the wells completely filled.  Microtransfer molding was used to create 
patterns of Matrigel buried in microwells or microchannels with dimensions ranging from 
100 to 800 μm and a height of approximately 200 μm as measured using a Nikon 
Microscope (ME600 Eclipse 3.0 Software).  Optical images of the patterned Matrigel can 
be seen in Figure 2-4 (a-c).  As seen in these images, μTM molding yielded Matrigel 
patterns with a uniform organization and homogeneity.   
 
 
Figure 2-4. Matrigel patterns created via micro transfer molding (a-d) and dry lift-off technique (e-h).   (a,b) 
Buried patterns of Matrigel in 200 μm wells.  (c) Buried patterns of Matrigel in 100 μm channels.  (d) Free 
standing 400μm structures of Matrigel.  (e,f) free-standing Matrigel structures (400 μm) following 
membrane release, and enlarged image of a free-standing Matrigel structure (g) free standing structure of 
Matrigel showing collagen fibers (400 μm). (h) Buried pattern of Matrigel (400 μm) in through-hole 
membrane surrounded by p-HEMA. Scale bars:  (red) 100 μm (black) 200 μm 
 
a) b) c) d) 
f) g) h) e) 
Residual Matrigel 
p-HEMA 
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In addition, free standing structures of Matrigel were also produced using this 
method.  Moreover, we treated the PDMS membranes with poly-HEMA in order to 
minimize the adhesion of the Matrigel on the PDMS surfaces and to promote deformation 
free-release of the gel structures.  Figure 2-4d shows a free standing Matrigel pattern 
created using poly-HEMA coated PDMS stamps.  As can be seen from the figure, the 
Matrigel structure remained intact with noticeable stability.  During the patterning 
process for μTM, the initial deposition of the Matrigel liquid precursor resulted in a layer 
of Matrigel covering the entire PDMS surface.  Despite using a glass slide to remove 
excess Matrigel, residual Matrigel was observed outside the pattern on the PDMS 
substrate.  The yield for generating free-standing structures of Matrigel using μTM 
(approximately 50%) was much lower than for buried patterns.  This is because the 
patterning process for free standing Matrigel involves removal of the PDMS membrane 
and as the membrane is peeled off the substrate, the shear stresses produced cause the 
fragile gels to deform and break off the substrate.  Thus we found that microtransfer 
molding was more suitable for creating well-defined buried patterns of Matrigel. 
 
PDMS Through-hole Membrane Fabrication and Matrigel Patterning via Dry-lift 
off Techniques 
 PDMS membranes with through-holes were produced by spin coating the PDMS 
pre-polymer onto a substrate containing circular posts of SU-8 photoresist.  The 
membrane thickness varied from approximately 80 to 120 μm as determined by the Zygo 
Newview 6200 Scanning White Light optical profilometer (Lamda Photometrics, United 
Kingdom).  These through-hole membranes were then used in the dry lift-off technique to 
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create different patterns of Matrigel.  The single layer dry lift-off patterning technique is 
similar to μTM molding using poly-HEMA treated PDMS membranes and was used to 
make free standing structures of Matrigel.  As can be seen in Figure 2-4e-g, the dry lift 
off technique produced nicely defined free standing Matrigel patterns with greater 
cleanliness than with μTM (Figure 2-4d).  This is because in dry lift-off, the Matrigel is 
introduced from the top of the through-hole membrane and as the membrane is lifted off 
the glass substrate, the excess Matrigel is removed with it.  The thickness of the free-
standing patterns was measured to be approximately 80 μm as determined by the optical 
profilometer.   
In addition, a dual-layer dry-lift off technique was developed to create buried 
patterns of Matrigel surrounded by poly-HEMA.  Figure 2-4h shows buried patterns of 
Matrigel surrounded by poly-HEMA created using this technique.  The use of two surface 
treated congruent through-hole membranes was beneficial for patterning two different 
materials.  The top membrane was used to prevent the deposition of Matrigel in areas on 
the poly-HEMA coated bottom membrane outside the well.  We found that with dry lift-
off technique, the yield for both buried and free standing patterns was approximately 80%.  
While the dual layer dry lift-off technique allows us to simultaneously generate patterns 
of Matrigel and poly-HEMA on a single substrate, the delicateness of the through-hole 
membranes and the difficulty with membrane alignment makes this method very 
challenging. 
Matrigel, like most hydrogels is also prone to rapid dehydration.  Matrigel is 
strongly influenced by environmental factors such as temperature and humidity [18].  To 
investigate the dehydration rate of Matrigel, we observed the change in mass of a small 
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droplet of water and Matrigel (~25 mg) in normal laboratory environment (20ºC and 50% 
relative humidity).  We observed a 20% mass reduction in Matrigel after 20 minutes and 
50% mass reduction after 50 minutes while only 10% and 25% mass reduction were 
observed in water after the same time duration (Figure 2-5).  This rapid evaporation of 
Matrigel can be disadvantageous during patterning as the vertical dimensions of the 
Matrigel patterns produced would be reduced significantly due to dehydration; however, 
the effects of evaporation could be minimized by placing the Matrigel patterns in a 
humidified incubator following patterning. 
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Figure 2-5. Evaporation of Matrigel compared with the evaporation of water under normal laboratory 
conditions.  Matrigel has a more rapid evaporation than water due to the temperature dependent gelation. 
 
3D Cell Culture and Epithelial Morphogenesis on Micropatterned Matrigel 
 Cell seeding density of approximately 1000 cells/ml resulted in one or two cells 
being placed on Matrigel islands (Figure 2-6(a-b)).  In our experiments, we found on 
average that approximately 50% of the Matrigel wells contained one or two cells.  Single 
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MCF-10A cells cultured in the presence of a protein-rich basement membrane complex 
like Matrigel develop into a solid structured mass composed of a polarized epithelial 
layer enclosing a central hollow lumen [1].  In order to ensure that the micropatterning 
process did not perturb the biological properties of Matrigel and thus did not alter the  
normal development of these cells, we compared different stages of the morphogenetic 
process in MCF-10A acini grown on our micropatterned Matrigel to MCF-10A cells 
placed in conventional 3D cell culture assays.  As expected, the cells placed in the 
micropatterned template adopted the usual spherical polarized morphology as seen from 
the phase contrast images in Figure 2-6.  The dimensions of the acini varied from 
approximately 25 to 80 μm in diameter which was comparable to the dimensions of acini 
obtained using standard 3D cultures [19-20].  
 
Figure 2-6. Phase contrast images of MCF-10A acini (a-d).  (a-c) Mammary epithelial acini following day 
10 of cell culture on micropatterned Matrigel. (d) MCF-10A acini in standard 3D culture on day 10. Arrow 
indicates overlapping acini in standard 3D culture. Scale bar: 100 μm 
 
 It has been previously reported that as early as day 8, the inner subset of cells that 
are not in direct contact with the matrix, begin to undergo apoptosis leading to the 
formation of a hollow lumen [20].  We used confocal microscopy to verify the 
c)b)a) 
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programmed cell death of centrally located cells and lumen formation (Figure 2-7). MCF-
10A cells were cultured on micropatterned Matrigel for 8 days and were fixed and stained 
with DAPI nuclear staining (blue) and antiserum directed against the cleaved, activated 
caspase-3 (red), a common marker of apoptosis.  In addition, we also stained for a 
number of integrin receptors such as alpha-5 and alpha-6, which are the major adhesion 
receptors that transduce signals from cell-cell and cell-ECM [21].  As can be seen from 
the confocal images, the DAPI-stained cross sections on individual acini showed caspase-
3 positive apoptotic cells in the center of the developing acini, whereas cells on the 
periphery that were in direct contact with the basement membrane remained viable.  
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Figure 2-7. Acini cultured in micropatterned Matrigel undergo apoptosis during 3D morphogenesis.  Single 
MCF-10A cells were plated on micropatterned Matrigel.  At day 8, resulting acini was fixed and 
immunostained with antibody to active caspase-3 (red).  Confocal images illustrate apoptotic cells in the 
center of acini.  Acini was also stained with antibody against integrin alpha5 to localize outer cell layer.  
Scale bar: 25 μm 
 
The organization of the outer layer of epithelial cells was delineated by alpha 5 
integrin localization at the cell-cell junction.  By day 16, we observed in Figure 2-8b, a 
completely hollow lumen in cells placed in the micropatterned Matrigel comparable to 
c) 
b)
d)
a) 
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the hollow acini formed by cells cultured in standard 3D conditions (Figure 8a).  In 
addition, we also detected the proper localization of integrin alpha 6 subunit at the basal 
surface of acini in micropatterned Matrigel comparable to standard 3D culture (Figure 
2-8a).  These results show that normal mammary epithelial cells placed in 3D conditions 
using our micropatterned template form normal acini structures with similar properties to 
standard 3D methods including normal acini size, formation of hollow lumen, and proper 
organization of an outer layer of epithelial cells.  
 
Figure 2-8. Acini on micropatterned Matrigel form hollow lumen and localize integrin receptors similar to 
standard 3D culture.  Confocal images of acini cultured using conventional 3D assays (a) compared to acini 
growing on micropatterned platform (b).  Day 16 acini show organized outer layer of epithelial cells 
enclosing hollow lumen as indicated by fixing acini and staining with nuclear stain Dapi (blue).  Acini was 
also stained with antibodies against integrin subunits.  Acini cultured on standard and micropatterned 
Matrigel show similar localization of integrin alpha 6 (red), in basal surface of acini, and integrin alpha 5 
(green), in cell-cell junctions.  Scale bar: 25 μm 
Dapi Integrin α6 Integrin α5 
a) 
b) 
Dapi Integrin α6 Integrin α5
Overlay 
Overlay 
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 A well described phenotype of human breast tumor cell lines is a lack of 
organized tissue structure with invasive properties when cultured in 3D conditions [21].  
In order to investigate the potential behavior of these carcinoma cell lines on our 
patterned Matrigel, we cultured MDA-MB-231 adenocarcinoma cell lines on our 
micropatterned Matrigel for 8 days and compared them to cells growing in standard 3D 
culture.  Figure 2-9 shows the phase contrast images of these cells.  As with conventional 
3D cultures, we found that these cells initially started out as individual cells within the 
micropatterned Matrigel (Figure 2-9a) and over time, proliferated in an uncontrolled 
manner to form disorganized and apolar masses with large invasive projections (Figure 
2-9(b-c)).  As can be seen in Figure 2-9, these cells grew very rapidly and soon invaded 
the underlying Matrigel.  This phenotype was similar to when MDA-MB-231 cells were 
placed in standard 3D culture (Figure 2-9d).   
 
Figure 2-9. Micropatterned Matrigel supports invasive phenotype of breast cancer cell.  Phase contrast 
images of MDA-MB-231 cells.  (a) Single MDA-MB-231 cell on micropatterned Matrigel (b-c) MDA-
MB-231 cells growing on micropatterned Matrigel following day 8 of culture, and  (d) MDA-MB-231 in 
standard 3D culture. Scale bar: 200 μm 
 
 
Taken together, these results validate the use of our micropatterned Matrigel 
template for examining normal epithelial tissue organization as well as tumor cell 
b) c) a) d) 
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phenotypes cultured in 3D conditions.  This template can be expanded for use in drug or 
gene screening capability to revert cancer phenotypes in a high-throughput manner.  
 
2.4 Discussion 
Hydrogel patterning using soft lithography techniques such as microtransfer 
molding (μTM) has been reported [16-17, 22].  However, the use of PDMS stamp to 
mold and release gel structures is often hindered by the tendency of gels molded against 
them to adhere to the hydrophobic membranes resulting in difficulty releasing the 
structures without deformation.  This problem becomes more serious when we try to 
make bulk micropatterns.  Several surface treatments have been applied to PDMS to 
minimize non-specific protein adsorption including plasma treatments [16, 23-25], 
grafting of reactive chains [16-17, 26-27], and coating of functional layers [16-17, 28-29].  
Oxygen plasma treatment was beneficial in our experiments as it allowed us to reduce the 
hydrophobicity of the PDMS membranes.  The surface contact angle of Matrigel liquid 
precursor was significantly reduced from greater than 90º to approximately 20º; thus 
allowing the material to wet the surfaces of the elastomeric membranes.  This was 
especially useful in microtransfer molding as we were able to eliminate the problem of 
partially filled wells and bubble formation within wells before gelation.  
Unfortunately, modification of PDMS with plasma alone is not sufficient for 
promoting deformation free release of Matrigel during patterning.  This may be due to the 
hydrophobicity recovery of the treated PDMS membrane [23].  In order to prolong the 
hydrophilic properties of the plasma treated membranes, additional surface coating was 
investigated.  With high concentration BSA (10% BSA in 1X PBS) coating, there was 
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some decrease in the adsorption of Matrigel; however, this was not sufficient to prevent 
the destruction of the Matrigel patterns during membrane release.  In addition, BSA 
adhesion on plasma treated PDMS was very poor and sometimes the BSA filled the holes 
of the membranes thus inhibiting their use for the subsequent Matrigel patterning. 
 The original role of poly-HEMA in our patterning process was to prevent cellular 
adhesion in regions in between Matrigel islands during the 3D culture.  However, we 
found a secondary use for poly-HEMA in that upon coating the surfaces of PDMS, it was 
possible to strongly minimize the adsorption of Matrigel on the PDMS molds and thus 
enable us to create free standing structures of Matrigel.  The adsorption of poly-HEMA 
on plasma treated PDMS surfaces exhibited prolonged hydrophilic properties as verified 
by the surface contact angle measurements (data not shown).  Poly-HEMA contains polar 
functional groups such as hydroxyl (-OH) which render its surfaces hydrophilic and 
allows it to react with water based solutions [30].  The free standing structures of 
Matrigel released from the treated PDMS membranes during μTM resulted in 
microstructures of Matrigel that were intact with noticeable stability. 
 Three different patterning techniques investigated in this research are compared in 
Table 2-1.  The advantage of microtransfer molding is that it is a relatively simple 
method for replicating the three-dimensional topography of an elastomeric membrane and 
it has been widely used for many applications in biomedical research [16-17, 31-32].  In 
addition, it is possible to create micropatterns with relatively small dimensions (≤ 200 
μm).  The main challenge with this method is that it is difficult to create clean patterns of 
Matrigel.  During the patterning process for μTM, the initial deposition of the Matrigel 
liquid precursor resulted in a layer of Matrigel covering the entire PDMS surface.  
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Despite using a glass slide to remove excess Matrigel, residual Matrigel is often found in 
unwanted areas surrounding the patterns.  On the other hand, dry lift-off technique uses 
through-hole membranes that can be used to pattern materials onto a substrate while 
preventing the deposition of materials in unwanted areas.  However, compared to PDMS 
replica molding, the fabrication of these through-hole membranes posed more challenge 
because the fragility of these PDMS membranes makes them prone to tear and damage 
during handling.  With the dual layer patterning technique, we were able to 
simultaneously pattern both Matrigel and poly-HEMA on a single substrate.  Another 
possible application of the dual-layer patterning technique is in co-culture systems [33], 
where two complementary cells are patterned and manipulated in a biological matrix. 
Table 2-1. Comparison of Bulk-Matrigel patterning techniques 
 Microtransfer Molding 
Single layer dry lift-
off 
Dual layer dry lift-
off 
1. Design restrictions 
 
 
 
 
Best suited for buried 
patterns of any shape 
and size.   
 
 
Suitable for free-
standing patterns.  
Features should be 
relatively simple (i.e. 
squares, circles, etc.) 
 
Suitable for both 
buried and protruding 
patterns. However, 
features should be 
simple e.g. circles, 
squares, etc. 
2. Membrane 
Fabrication and 
Handling 
 
 
 
Easy to make – PDMS 
replica molding.   
 
 
 
Membrane fabrication 
requires control over 
spinning parameters, 
membranes are thin 
and difficult to 
handle. 
Membrane fabrication 
requires control over 
spinning parameters, 
membranes are thin 
and difficult to 
handle. 
3. Surface 
modification 
 
Required Required  
Required 
 
4. Alignment Not Required Not Required Required 
5. Clarity of Patterns Poor Good  Excellent 
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 It should be noted that in creating free standing structures of Matrigel using both 
μTM and dry lift-off techniques even after surface modification did not result in 100% 
yield (i.e. some patterns were damaged during release).  In addition, the structural 
reliability of the Matrigel micropatterns is a function of various geometric parameters 
such as membrane thickness, diameter, hydrogel thickness and gaps between patterns.  
The Matrigel structures are easily sheared during membrane release, and the rate at which 
the PDMS mold is removed should be very slow to minimize the stresses on the patterns.  
With μTM, there are no constraints on the features that can be used to produce buried 
patterns.  However, to create free-standing patterns using both techniques, the features 
should be relatively simple (i.e. circles, squares, etc.).  In our experiments, we found that 
intersecting patterns are more difficult to make, often resulting in distortion of patterns 
following membrane release.   
The usefulness of the micropatterned Matrigel can be maximized when single 
mammary epithelial cells are placed on each micropatterned gel, and the patterned 
Matrigel can provide the necessary microenvironmental cues that will enable each cell to 
organize into structures that closely mimic their native architecture in vivo.  The optimal 
choice of matrix for 3D mammary epithelial cell culture is Matrigel since these cells are 
unable to form acini on other matrices such as collagen [3].  By controlling the cell 
seeding density, we were able to achieve single cell placement on the micropatterned 
Matrigel, and we have shown here that the micropatterned Matrigel was still functional in 
providing the structural and biochemical signals necessary for 3D morphogenesis of both 
normal and aberrant epithelial cell organization. In the future, in order to maximize the 
number of individual cells that are placed on Matrigel islands, other methods to localize 
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single cells within the micropatterned Matrigel such as dielectrophoresis will be explored 
[34].  We envision the development of a completely miniaturized 3D culture platform 
that will serve as a cell based assay that can be used in basic cell biological studies to 
identify molecular pathways regulating normal tissue architecture, for example in use for 
RNAi-based screens.   
2.5 Conclusion 
We have constructed bulk micropatterns of Matrigel that can be used as a 
platform for 3D epithelial cell based assay.  Both buried and free-standing micropatterns 
of Matrigel were created using modified soft lithography techniques such as 
microtransfer molding (μTM) and dry lift-off technique.  Surface modification of PDMS 
with oxygen plasma followed by treatment with poly-HEMA was sufficient to promote 
deformation-free release of Matrigel patterns.  In addition, a novel dual-layer dry lift-off 
technique was developed to simultaneously generate patterns of Matrigel and poly-
HEMA on a single substrate.  Moreover, we demonstrated the utility of our 
micropatterned Matrigel for 3D culture of both normal mammary epithelial cells and 
breast cancer cells with comparable phenotypes to standard culture techniques.  Our 
microfabricated platform for studying breast cancer cells can not only recapitulate normal 
epithelial structure and function but can also allow for more detailed understanding of 
tissue dysfunction in disease states and provides a more realistic milieu for modeling 
therapeutic intervention.  This platform can also be used in automated high throughput 
screening systems or combined with microfluidic devices that will allow for multiple 
laminar streaming of important biochemical reagents or drugs.  We believe that this work 
will enable the development of completely miniaturized 3D cell-based platforms with a 
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wide variety of applications in cancer biology, tissue engineering, as well as gene/drug 
screening technology. 
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CHAPTER 3. MICROPATTERNED MATRIGEL TRACK FOR 3-D SINGLE 
BREAST CANCER CELL MIGRATION AND INVASION 
3.1 Introduction 
Cancer metastasis is a multi-step process that involves the orchestrated movement 
of a cancer cell from its tissue of origin to secondary sites including major organs such as 
the lung, liver, and brain [1].  It is also known to be the cause of 90% of cancer related 
deaths [1].  The malignant transformation of cancer cells and subsequent relocation is 
influenced by both alterations in genetic make-up as well as extrinsic factors in the tumor 
microenvironment [4-6].  Recent advances on this subject has been centered primarily on 
the first critical step in the process of invasion, i.e. migration of cancer cells through 
extracellular matrix (ECM) domains mediated by chemical gradients in the environment 
[2-3].   Breast cancer cells can serve as appropriate in vitro models for understanding 
mechanisms of migration and invasion.  These cells are known to invade across 
interstitial tissues in response to gradients of biochemicals such as growth factors 
including epidermal growth factor (EGF) [2-3].  From both a clinical and basic research 
perspective, a more detailed understanding of the mechanisms of breast cancer 
migration/invasion is needed in order to identify better diagnostic markers and 
appropriate therapeutics. 
Common in vitro assays (e.g. Boyden/transwell, scrape/wound-healing, etc.) for 
studying cell migration mechanisms are typically conducted on two-dimensional (2D) 
platforms [4-6].  While these monolayer systems provide a convenient and rapid means 
for analysis, they lack physiological context and do not adequately represent the in vivo 
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tumor microenvironment.  Three-dimensional (3D) models utilizing biological based 
matrices such as collagen and Matrigel have also been developed.  These 3D systems 
allow biological studies in a setting that closely resembles the native microenvironment 
of cells in vivo [7-8].  These models are currently being used to understand genetic 
components governing normal cell behavior and how variations in these factors result in 
cancer progression.  Traditional 3D migration assays are available in the form of 
modified Boyden Chambers, which consists of two compartments separated by matrix-
coated filters [9-10].  Cells are seeded in one compartment and chemotactic factors are 
placed in the other compartment, generating a chemical gradient across the thickness of 
the filter.  The invasive potential of the cancer cells are quantified by counting cells that 
made it across the reverse side of the filter.  These end-point assays create chemical 
gradients over large cell populations, making it difficult to relate individual cell motility 
to the extracellular environment.  In addition, these methods do not allow for direct 
optical imaging of cell migration nor do they allow long-term tracking of the cell 
invasion process.  Therefore, there is a need for simpler, experimentally tractable models 
that provide a means to analyze individual cell migration and invasion in a setting that 
takes into account the critical interaction between a cell and its microenvironment. 
Recent advances in microfabrication technology has led to the development of 
microfluidic systems capable of handling very small (microliter – nanoliter) volumes of 
fluid and are being incorporated into bio-related fields [11-13].  These systems enable 
biological-based experiments with micrometer preferences, while minimizing reagent 
consumption and lowering associated costs.  An important feature of microfluidic devices 
is that the fluid flows at the small length scales are low Reynolds number flows, in which 
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mixing occurs by diffusive transport; therefore, these devices can be used to effectively 
generate temporally stable gradients of small biomolecules.  Various researchers have 
taken advantage of this technology by building devices to study cell migration.  As an 
example, Jeon et al [14] created a microfluidic gradient generator to observe the 
movement of neutrophils towards various concentrations of a chemoattractant.  More 
recently, Walker et al [15] used a similar system to create gradients of the chemokine 
CXCL8 in order to study the chemotactic response of leukemia cells.  Although current 
microfluidic systems are able to rapidly direct multiple concentration gradients using 
intricate, interconnected networks of microchannels, they may not be suitable for cancer 
related studies as they lack the 3D housing necessary to provide cancer cells with the 
appropriate physiological cues that mediates migration and invasion.  Our approach to 
cell migration is better suited with a design that recreates the in vivo 3D organization and 
tissue microenvironment.  Our design builds on 3D assays previously described by 
Bissell et al, where cells are either overlaid in an exogenous ECM rich matrix such as 
Matrigel (Figure 3-1a), or the cells are embedded within the matrix proteins  (Figure 3-1b) 
[16].  In addition, this simple design can facilitate transient evolution of chemoattractant 
concentration gradients while promoting the 3D cultivation of single cancer cells. 
In this study, we present a microfabricated platform that is composed of 
micropatterned Matrigel tracks and microchannels for studying individual cancer cell 
migration and invasion in a 3D microenvironment (Figure 3-1).  We have previously 
reported that micropatterned Matrigel can support the 3D cultivation of both normal and 
breast cancer cells with comparable phenotypes as standard macroscale 3D techniques 
[17].  We have now combined this micropatterned Matrigel with microfluidics 
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technology in order to study cancer cell migration and invasion under various 
biochemical conditions.   
 
Figure 3-1. A schematic diagram of the microfabricated platform for individual breast cancer cell 
migration/invasion studies in 3D.   A single cell is placed on (a) or embedded (b) on one end of the 
micropatterned Matrigel (3D Growth assay).  The growth factor is introduced on the other side of the 
microchannel to create the chemical gradient. GF = Growth Factor. 
 
 
Buried Matrigel tracks were created using modified micro transfer molding 
techniques as previously described [17].  Single fluorescently labeled metastatic breast 
cancer cells (MDA-MB-231) were placed on one end of the micropatterned track.  A 
second microchannel was then aligned over the system in order to create a fluidic housing 
and to promote the 3D cultivation of our cells.  Concentration gradients of EGF were 
created by simply pipetting a small volume of solution into the opposite end of the 
microchannel.  EGF molecules then diffused along the channel to generate concentration 
gradients within the channel. We successfully observed the directed movement of 
individual cells towards an increasing concentration of epithelial growth factor and 
measured cell invasion velocities ranging from 0.1μm/min to 0.5 μm/min.  By embedding 
the cells within the micropatterned Matrigel, we were able to observe the movement of 
 
 
Migration/Invasion Chamber 
Matrigel 
Breast 
Cell 
Side view 
 
  
      
Growth Factor 
Migration/Invasion Chamber 
GF Gradient  
Matrigel 
Breast 
Cell 
Side view 
3D Overlay Assay 3D Embedded Assay 
GF + Media 
(b) (a) 
  
93
cells through the Matrigel layer.  We also observed changes to the Matrigel structure 
during the cancer cell invasion process.  It is believed that this novel platform can enable 
real-time visualization and quantitative measurement of cell movement within an 
analytically defined microenvironment, while providing easy parallelization for high-
throughput studies. 
     
3.2 Materials and Methods 
Polydimethylsiloxane Device Fabrication  
Figure 3-2 shows the schematic process flow for the cell migration/invasion 
studies.  Polydimethylsiloxane (PDMS) membranes with microchannels (length = 5000 
µm, width = 300 µm, height = 100 µm) were fabricated as previously described [18].  
Briefly, membranes were created using standard replica molding over photoresist masters 
using silicone elastomer (Sylgard 184, Dow Corning Corporation).  The photoresist 
masters were prepared by spin coating negative photoresist, SU-8 2035 (Microchem 
Corporation) over borosilicate glass, soft baked, and crosslinked by UV for 30 seconds.  
Post-exposure baking was followed by development in SU-8 developer (Microchem 
Corporation) and cleaning in isopropanol.  For all experiments, two identical PDMS 
membranes were fabricated.  The PDMS molds were prepared in a 10:1 ratio (prepolymer: 
curing agent), poured over SU-8 master, degassed, and cured in convective oven at 80ºC 
for 2 hours.  Once polymerized, PDMS membranes were peeled off the master, cut down 
to size, and stored until it was ready for use.  This process yielded rectangular 
microchannels with heights of approximately 100 μm.   
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Figure 3-2. Schematic of the process flow for the cell migration/invasion studies.  Fabrication process 
begins with photolithography to define the photoresist template, then PDMS micromolding to create the 
microchannel membrane.  Matrigel micropatterning is achieved via microtransfer molding technique 
followed by single cell placement on the micropatterned gel.  A second identical PDMS membrane is 
aligned to create the fluidic housing and EGF gradient. 
 
Matrigel Micropatterning 
Growth factor reduced Matrigel (same as the one used in Chapter 2 for 3D culture, 
BD Biosciences) was removed from frozen storage (-20ºC) and placed on ice bath to 
thaw until ready for use.  Gel patterns buried in microchannels were created using a 
similar technique to the one previously described [17].  The PDMS membranes used for 
patterning were initially subjected to a 30 seconds oxygen plasma treatment (Harrick 
Plasma PDC 32G) to promote the wettability of the membrane with the liquid Matrigel 
precursor.  A small droplet of the gel in the liquid phase was then gently placed on the 
treated membrane (taking care not to generate bubbles).  A glass slide was then gently 
slid off the membrane to remove any excess gel, leaving behind patterns of Matrigel 
buried within the microchannels.  Complete gelation was achieved by placing the device 
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in a humidified incubator at 37ºC for 15 minutes.  For the invasion assay, the PDMS 
microchannels were incubated overnight at 37ºC with cell culture media.  The culture 
media was then removed and single cells were aligned along the channel (See section 
2.3).  Following cell adhesion, liquid Matrigel was deposited over the microchannel, 
covering the cell surface.  A glass slide was gently slid across the channel surface to 
remove excess Matrigel.  The device was then placed in the incubator to allow for 
complete gelation of the Matrigel and subsequent processing (Figure 3-2). 
 
Cell preparation, Alignment and 3D Culture 
Human breast adenocarcinoma cell lines, MDA-MB-231 were obtained from 
American Type Culture Collection (Manassas, VA) and maintained as previously 
described [17].  Cells were infected with retroviruses containing the green fluorescent 
protein (GFP) plasmid (pMX-GFP) as previously described [19, 34].  Briefly, cells were 
plated at 5 x 105 cells per 10 cm plate.  Cells were allowed to recover overnight and then 
exposed to viral particles using an appropriate MOI to yield 80% – 100% infection, based 
on GFP expression evaluated by a fluorescent microscope (Leica).  Single cell placement 
in the device varied based on type of assay i.e. migration or invasion (Figure 3-1).  For 
single cell placement on the micropatterned gel (migration assay), we used an auxiliary 
microchannel with very thin dimensions (Length = 1 cm, Width = 50 µm, Height = 30 
µm).  Access holes are punched into the microchannel using sharp stainless steel metal 
tubing.  This microchannel was then aligned perpendicularly to the channel containing 
the micropatterned Matrigel (Figure 3-2).  The cell seeding density was controlled and 
reduced to very low levels, approximately 500 cells/ml.  Cell suspension was introduced 
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in the auxiliary channel at one end of the microchannel.  By applying gentle suction to 
the other end of the channel, the cells are pulled through the microchannel in a single file.  
Once we observe single cell placement on the micropatterned region via an inverted 
microscope, the device was placed in the incubator for approximately 1 hour to allow cell 
adhesion.   The process for the invasion assay uses a similar method, except that the cells 
are aligned directly on the bottom of the PDMS microchannel (pretreated overnight with 
culture media) prior to Matrigel patterning thus ensuring total embedment of cells within 
the Matrigel. Following this process, a secondary microchannel (with access holes) 
identical to the one containing the micropatterned gel and single cell was carefully 
aligned directly over the device to create a fluidic housing.  Once adequate alignment was 
achieved as observed by an optical microscope, the channel was filled with cell culture 
medium containing 2% Matrigel.  This device was then placed in the incubator for 3D 
cell cultivation and subsequent processes.  
 
Epidermal Growth Factor Gradient Generation 
The device was composed of two identical PDMS membranes.  One containing 
single breast cancer cells on or embedded within the micropatterned matrix, and the 
second one aligned on top to create the microfluidic housing.  The chemoattractant used 
for all experiments was epidermal growth factor (EGF).  A small volume of EGF 
(equivalent to 10% of the channel volume) at various concentrations (0, 25, 50 ng/ml) 
was loaded into the outlet port of the top microchannel.  EGF molecules then diffused 
along the channel length to generate concentration gradients that are well described by 
Fick’s Law [20-21].  Ligand-receptor binding between cells positioned within the channel 
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then initiates directed cell movement that can be observed via a fluorescent microscope.  
Each experiment was performed in duplicate; negative controls were set-up with no EGF 
gradient and the cell response was compared side by side.  For the invasion assays, no 
EGF gradient was created; instead, the EGF was homogenously mixed with the Matrigel-
Media solution and plated over the micropatterned gel.   
 
Cell Imaging and Migration Data Analysis 
Cancer cell morphology, Matrigel structure, and migration strategies were 
visualized using an inverted/fluorescent microscope (Leica DMIRB) and acquired using a 
specialized digital compact camera.  Images were acquired every 24 hours (with the cell 
location noted relative to the inlet port) and the total cell displacement (length of cell 
displacement between starting and final position) was analyzed using the eclipse software 
(ME600 Eclipse 3.0 Software, Nikon Microscope) from converted jpg static images.  The 
migration speed of the cells was then determined by dividing the total displacement over 
the total elapsed time.  
 
3.3 Results 
Microscale 3D Breast Cancer Cell Culture 
Buried micropatterns of Matrigel were created in order to cultivate single MDA-
MB-231 cells in 3D.  Matrigel is a unique biomatrix hydrogel with properties strongly 
influenced by environmental factors such as temperature and humidity.  We observed that 
even under the same patterning conditions, the resulting micropatterns had visible 
variations in morphology, probably due to differences in drying rates (Figure 3-3a-c).  
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However, after introducing the liquid cell suspension over the micropatterned gel, these 
differences were no longer visible and the micropatterned Matrigel assumed a smooth 
and uniform morphology (Figure 3d).   
 
 
Figure 3-3. Variation in Matrigel morphology during micropatterning (Phase contrast microscopy).  
Observed variations in the Matrigel morphology under similar patterning conditions (Temperature 20ºC 
and relative humidity of 50%).  (a-c) Matrigel micropattern morphology in linear microchannels. (d) 
Smooth Matrigel morphology in the presence of media.  Scale bars: 100 μm 
 
We have previously demonstrated that single cells can be cultured on 
micropatterned Matrigel and that the gel was still functional in providing the structural 
and biochemical cues necessary for the 3D morphogenesis of normal epithelial cell 
organization [Thesis Chapter 2].  As an additional test, MDA-MB-231 cells were also 
cultured on micropatterned Matrigel housed in a microfluidic device.  As expected, the 
cells grew rapidly and formed their typical invasive cellular projections (data not shown).  
This provided the preliminary basis for the use of our micropatterned gel for cancer cell 
migration studies.   
 
(a) (b) (c) (d) 
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Effect of EGF Gradient on MDA-MB-231 Cell Migration 
We investigated the influence of EGF on the migration of single MDA-MB-231 
cells.  Individual breast cancer cells are known to employ a mesenchymal migration 
strategy [22-23] that is characterized by an initial enlargement of the cell body, followed 
by a bi-directional elongation of the cell and extension of cell processes in a focused 
direction.  We were able to observe this polarized morphology in MDA-MB-231 cells 
cultured in our micropatterned Matrigel.  As can be seen in (Figure 3-4a-c), the cell 
initially started as a single cell with a spherical morphology and as time progressed, the 
cell body grew to more than twice its initial size followed by development of a spindle-
shaped morphology that is characteristic of a mesenchymal migration mode.  We also 
observed in some cases that some cells appeared to proliferate and migrate preferentially 
in the direction of the concentration gradient in a manner reminiscent of a collective cell 
migration mode (Figure 3-4d-e).  The leading cell displayed mesenchymal characteristics 
with an elongated morphology, while the remaining cells followed behind (Figure 3-4e).  
We analyzed over 60 cells and found that in most of our experiments (approximately 
70%) of the time, the cells exhibited a mesenchymal migration morphology. 
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Figure 3-4. MDA-MB-231 cells exhibit mesenchymal and collective migration strategies. (a) Single MDA-
MB-231 cell placed on micropatterned Matrigel. (b) Phase contrast image of cell displaying a polarized 
morphology and bidirectional extension of cell body (Mesenchymal mode) (c) fluorescent image of the 
same cell showing cell protrusions at the cell end.  (d) Phase contrast image of cells displaying a collective 
migration strategy.  (e) Fluorescent image of same cells show leading cell displaying a mesenchymal 
morphology, while trailing cells follow behind.  Scale bars: 30 μm 
 
 
Moreover, we investigated the effect of EGF on the migratory capacity of MDA-
MB-231 cells by comparing the results of cells cultivated in the absence of EGF with 
cells grown in the presence of an EGF gradient.  We observed that cells cultivated in the 
absence of an EGF gradient remained localized, with the cells growing at a much slower 
rate while still extending the usual disorganized cellular projections (data not shown).  
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However, we observed that on the micropatterned Matrigel with the EGF gradient, over 
90% of the cells moved preferentially in the direction of the increasing concentration 
gradient over the duration of all experiments (Figure 3-5a).    
 
 
Figure 3-5. MDA-MB-231 cell migration towards EGF gradient on micropatterned Matrigel.  (a) 
Fluorescent image of the movement of single MDA-MB-231 cell on micropatterned Matrigel towards EGF 
gradient.  (b) Bar graph showing migration velocities measured at various EGF concentrations (0, 25, and 
50ng/ml).  Cell migration velocities increase with increasing concentration gradient.  Scale bars: 100 μm. 
 
 
Cell 
EGF Gradient 
 Day 1 
Day 3 
Day 5 
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0 25 50
EGF Concentration (ng/ml)
M
igration Velocity (µm
/m
in)
(a)  
(b)  
 
   
      
Growth Factor
Migration/Invasion Chamber
GF Gradient  
Matrigel  
Side view 
3D Overlay Assay 
  
102
By calculating the total displacement of the cells and dividing that by the elapsed 
time, we were able to determine the migration velocities of our cells.  Twenty cells were 
analyzed over a period of 5 days for each set of experiments.  The total distance traveled 
by the cells was calculated and the velocity determined.  We measured migration 
velocities ranging from 0.1μm/min to 0.5μm/min.  Figure 3-5b shows the average 
velocities measured for each set of experiments.  These migration velocities fall within 
the ranges of velocities previously reported for migrating cancer cells (0.1 – 2 µm/min) 
[24-25].  Table 3-1 shows the effect of EGF concentration (0, 25, and 50 ng/ml) on 
MDA-MB-231 cell migration.  As expected, the cell migration velocity increased with 
increasing EGF concentration. 
 
Table 3-1. Effect of EGF concentration on MDA-MB-231 Cell Migration. Data is based 
on average values (± standard deviation) 
Concentration (ng/ml) 0 25 50 
Net cell displacement (µm) 83.56 ± 13.68 505  ± 47.3 1592  ± 99.6 
Speed (µm/min) 0.014 ± 0.003 0.08  ± 0.01 0.27  ± 0.02 
No. of cells analyzed 20 20 20 
 
 
Cell Invasion and Matrigel Degradation 
Current research suggests that the dissemination of cancer cells in vitro requires 
the proteolytic degradation of the ECM barrier [24, 26-27].  In order to study the invasive 
potential of MDA-MB-231 cells utilizing our microfabricated platform, we embedded 
single cells in the micropattterned Matrigel track.  A homogenous EGF-media mixture 
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was placed over the embedded cells and replaced every 4 days for the duration of the 
experiments.  Following a few days, we started to observe noticeable changes in the 
matrix morphology surrounding the embedded cell.  The Matrigel fibers appeared loose 
with compromised integrity.  Figure 6 shows images of the Matrigel before degradation 
and Matrigel after cell invasion.  Throughout the invasion process, the cell remained 
viable as verified by fluorescent microscope showing GFP positive expression by the 
cells.  However, during the initial micropatterning process for the invasion assays, many 
cells did not survive, likely due to the low initial Matrigel temperature (4ºC) and the 
initial force applied to create the buried patterns.  Therefore, we were able to observe 
these matrix damages in only 4 cases. 
 
 
Figure 3-6. Matrigel degradation following MDA-MB-231 cell invasion.  (a) Phase contrast image of 
buried MDA-MB-231 cell in micropatterned Matrigel.  (b) Image showing cell invasion through the 
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Matrigel and loose Matrigel fiber strands. (c) Low magnification view (5x) of the entire channel showing 
boundary of Matrigel degradation. (d) Image showing complete loss of Matrigel fibers surrounding the cell. 
 
 
3.4 Discussion 
It is well known that the context (i.e. the microenvironment) with which cells are 
cultivated and manipulated in vitro is critical for the development or retention of normal 
tissue function [28-29].  This microenvironment becomes even more relevant in the study 
of cancer cell migration and invasion.  Cancer cells in vivo are able to rapidly navigate 
their way to the blood vessels, compared to the slow random movement of cells in culture 
[35-36]. Moreover, tumor cells can use several modes of motility, such as mesenchymal 
or amoeboid, enabling them to invade surrounding tissues of varying matrix densities 
[24].  These characteristics of cancer cells indicate that the phenotype of cell motility is 
readily compliant to the microenvironment in which the cells find themselves [36].   
In the in vivo environment, cancer cells interact with the extracellular matrix, 
which not only provides structural support for cells but also provides important signals 
that govern proliferation, organization, and survival [28-29].  These critical cellular 
interactions must be recreated in any platform that is to be used for these types of studies.  
Our approach to studying cell migration takes into account this factor by incorporating 
exogenous ECM in the form of Matrigel, a unique biomatrix hydrogel that contains 
essential proteins found in the native tissue into our design [8]. Moreover, the use of 
microfabrication technology enables us to impose known concentration gradients over the 
cells, mimicking the in vivo physiochemical environment [13-14].  By micropatterning 
the Matrigel, we have created a platform that can be adapted for high throughput 
screening of drugs and genes targeted against invasion and possibly metastasis. 
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In the context of cancer research, single cell analysis is important in order for 
scientists to be able to understand fundamental differences between a normal cell and a 
cancer cell.  A more precise understanding of these disparities could lead to development 
of improved diagnostic markers and better treatments for cancer.  A significant limitation 
of macro-scale approaches is that single cell isolation is very difficult to achieve.  In our 
design, we were able to isolate individual cells on the micropatterned Matrigel.  In order 
to achieve single cell placement in our device, we investigated different initial cell 
seeding densities and microchannel dimensions.  We found that a low cell seeding 
density of 500 cells/ml through a narrow microchannel width of 50 μm resulted in one or 
two cells being placed on the micropatterned gel.  It is important to note that not all cells 
had a natural propensity for migration.  To avoid issues with non-motile cells, we 
selected for aggressive phenotypes by initially culturing MDA-MB-231 cells in 3D and 
visually screened for cells with larger invasive cellular protrusions.  Aggressive cells 
were collected using a pipette and were passaged, while nonmoving cells were not 
selected for analysis. 
Unlike two-dimensional cell migration, 3D cell movement is more complicated, 
as the cells are required to adjust morphologically to the 3D environment in order to 
migrate more effectively through the ECM barrier [30].  Cancer cells use various 
migration strategies in 3D microenvironments [22-23, 30].  Some cancer cells including 
epithelial carcinomas are known to employ a mesenchymal migration strategy in 3D, 
although it is possible for some cells to alter their migration strategies to fit their local 
environment [24].  For example, migrating cancer cells can undergo a mesenchymal to 
amoeboid (a round morphology characterized by rapid cell movement) transition to 
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facilitate a more rapid migration [22].  We observed basic characteristics of a 
mesenchymal migration mode such as extension of the lamelliopodia and bi-directional 
elongation of the cell body towards the chemical gradient.  Migrating MDA-MB-231 
cells adopted a bi-polar, spindled and elongated shape and appeared to proliferate in the 
direction of the EGF gradient (Figure 3-5a).  In addition, some cells migrated as a group 
consisting of multiple cells, with a leading cell guiding their movement. 
A critical early feature of the metastatic process is the invasion of cancer cells 
through the  surrounding basement membrane that eventually leads to extravasion 
through blood vessels and subsequent reentry to distant tissues [24, 26-27, 31].  
Understanding this process of cell invasion will enable researchers to develop novel tools 
that can be targeted against inhibiting this phenotype.  The micropatterned Matrigel in 
our device mimics the basement membrane that provides structural support and works as 
a barrier against tumor cells [7].  This makes it physiologically relevant for in vitro 3D 
cell migration and invasion studies.  Cells embedded within the micropatterned gel were 
able to travel through the Matrigel network while destroying the gel barrier.  This is 
consistent with invasive cell behavior patterns through other ECM components such as 
collagen and fibronectin [32-33].  The cells did not move through the Matrigel in a 
straight line, instead the cells traveled through multiple layers in a zigzag like fashion. 
The morphological damages observed in the Matrigel structure provide evidence for the 
proteolytic action of ECM-degrading enzymes like matrix metalloproteinases (MMPs) as 
a requirement of 3D cell migration/invasion. 
Taken together, our results suggest that this simple device would find many useful 
applications as a 3D model system to study various aspects of cancer biology research for 
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example in areas requiring measurement of cancer cell migration kinetics in 3D or as a 
platform to test or screen chemical inhibitors of cell invasion.  
 
3.5 Conclusion 
We have developed a novel platform that can facilitate the study of individual 
cancer cell migration and invasion.  This platform consists of embedded Matrigel 
microtracks and a microchannel.  Single cells were seeded at the start line of the Matrigel 
microtracks and EGF was introduced at the finish line via microchannel.  Using this 
platform, we successfully exposed MDA-MB-231 cancer cells to various EGF gradients, 
and quantitatively characterized the migration of individual cells in various 3D conditions.  
Unlike macroscale migration assays, our platform enables us to introduce known 
concentration gradients over single cancer cells and measured individual cell migration 
distances and velocities.  Thus, allowing us to directly relate individual cell motility to 
the extracellular environment.  We also observed the invasive nature of these cells as they 
moved through the Matrigel layer.  We observed morphological changes such as 
degradation of the Matrigel network and loss of Matrigel fibers during the cell invasion 
process.  We believe that this research will create opportunities to understand the 
influence of chemicals on invasive behavior of cancer cells in 3D environments and may 
lead to the development of novel high-throughput systems for screening potential 
inhibitors of breast cancer metastasis.  
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CHAPTER 4. NUMERICAL ANALYSIS OF THREE-DIMENSIONAL 
SINGLE BREAST CANCER CELL MIGRATION TOWARDS 
AN EGF CONCENTRATION GRADIENT 
 
4.1 Introduction 
Mammalian cells under physiological conditions are surrounded by other cells, 
extracellular matrix proteins (ECM), interstitial fluids, and are subjected to both physical 
and chemical cues that vary spatially and temporally.  Directed migration is an example 
of a cell’s response to chemical gradients present in the cellular microenvironment, and is 
a subject of interest for many cancer researchers [1-3].  Gradients of growth factors, such 
as epidermal growth factor (EGF) have been shown to promote the migration of breast 
cancer cells.  Three-dimensional (3D) models utilizing biological based matrices such as 
Matrigel have been developed to study the process of cell migration [4-5].   
In this thesis, we have previously developed a new method for studying cell 
migration by combining 3D culture models and microfluidics technologies in order to 
better represent the in vivo migration process [Chapter 3].  The developed platform was 
composed of two identical microfluidic channels: one housing single breast cancer cells 
cultivated on a micropatterned Matrigel track (to mimic the 3D tissue microenvironment) 
and the second channel to create the microfluidic housing and the growth factor 
concentration gradient (Figure 4-1).  Using this platform, we were able to observe the 
preferential movement of MDA-MB-231 (a breast adenocarcinoma cell line) towards the 
EGF gradient and measured migration velocities ranging from 0.1 – 0.5 µm/min.  
However, we believe that in order to fully understand this cellular migration process, it is 
important to model the diffusion characteristics of EGF in terms of the concentration 
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profiles and resulting gradients.  The modeling results can provide useful information on 
local concentration gradients very near the cell surface.   The overall goal of this study 
was to derive a numerical model of the cell movement, which is able to reproduce results 
of experimental observations. 
 
Figure 4-1  Schematic of the microfluidic device for cell migration studies. The top microchannel houses 
the media and the bottom channel contains the micropatterned Matrigel. 
 
In this study, we consider a mathematical model of cancer cell migration on a 
tissue like matrix, which focuses on the response of single MDA-MB-231 cell to a 
concentration gradient EGF.  The domain of interest consists of a water-like medium 
layer on top of a Matrigel layer.  The diffusion of EGF concentration throughout the 
domain was solved by a finite element method using commercially available software, 
COMSOL multiphysics.  The diffusion coefficient of EGF in medium was calculated 
using a previously developed empirical formula [8], while that in Matrigel layer was 
estimated after a careful study of the characteristics of the thin two-layer diffusion 
problem.  An empirical relationship between the cell migration rate and the growth factor 
gradient was established based on previous experimental results obtained previously 
[Chapter 3].  The cell migration was then numerically calculated from the modeled cell 
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migration rate.  The cell migration results obtained from the numerical computations 
showed an agreement with experimental results. 
 
4.2 Modeling Concentration Gradient 
The governing equations in transport processes such as the diffusion equation and 
conservation of mass equations can help us to determine important transport properties 
such as concentration profile, concentration gradients, and diffusion fluxes [6-7].  In 
theory, these equations are a set of coupled differential equations that are solved for a 
given problem; however, in some cases, many of these equations are very difficult to 
solve analytically.  Therefore, computational mechanics provide a means for us to 
approximate solutions to these equations using a number of techniques such as finite 
difference, finite volume, and finite elements methods. 
In this section, we will first present an analytical model of the EGF diffusion in 
the microfluidic channels using a single layer approximation (i.e. negligible Matrigel 
layer).  The second modeling approach takes into consideration the diffusion of EGF 
through the Matrigel layer and is based on a dual layer modeling approach.  A 
computational software (COMSOL Multiphysics) was employed to solve the dual layer 
problem.  Comsol Multiphysics is an industry standard computational modeling software 
that uses the finite element method to simulate transport properties.   
 
Single Layer Model – Analytical Modeling of EGF Diffusion in Microfluidic Channel 
The variation of EGF concentration was determined by assuming that the 
diffusion of EGF in the microchannel follows the Fick’s law (a law describing the net 
movement of materials from areas of high concentration to a low concentration region).  
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In this single layer case, we assumed that the underlying Matrigel layer can be neglected 
and therefore, the flux of EGF through the Matrigel layer was negligible (Figure 4-2).   
 
 
Figure 4-2.  Single Layer Modeling Domain – Region Containing Media 
 
Considering an initial uniform EGF concentration in the y direction and constant 
properties of EGF, then the diffusion equation is reduced to the simplified transient one-
dimensional form (Equation 4-1):  
2
2
x
CD
t
C
∂
∂=∂
∂    (4-1) 
where C = C(x,t) and D = Diffusion coefficient.  The boundary conditions are such that 
there is no diffusion flux into the wall and an initial condition of a uniform concentration 
of EGF localized (Ci) to region 1.  In order to solve this initial-boundary value problem 
mathematically, we took an approach of combining the solutions of three initial value 
problems by superposition to obtain a general solution of the form: 
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The diffusion coefficient of EGF in cell culture medium was obtained via Young’s 
approximation [8]: 
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where T is the absolute temperature, η is the viscosity of solution, and M is the molecular 
weight of the chemical. The molecular weight of EGF provided by the manufacturer (BD 
Biosciences) is 6000 Da. Under the experimental conditions, T=310 K and η is 0.84 
mPa.s (media viscosity at 37ºC – neglecting the 2% Matrigel in the media) [9], so that D1 
is calculated to be 1.69x10-6 cm2/s in the media region.  Matlab software was used to 
generate plots of the concentration profiles under the one-layer approximation.   
 
Dual Layer Model – Computational Modeling of EGF Concentration in Microfluidic 
Channel 
The second approach to this problem takes into consideration the Matrigel layer.  
In reality, Matrigel is a porous hydrogel that can swell in response to various fluids. 
Therefore, it is possible that there is some diffusion of EGF through the Matrigel Layer.   
 
Figure 4-3.  Dual Layer Modeling Domain – Region Containing Media and Matrigel 
 
By assuming that the initial chemical is uniform in the lateral direction (z-axis) and 
absorption of chemical into the wall is negligible, the problem falls into a 2-D diffusion 
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problem with two layers as illustrated in Figure 4-3. The governing equation for 2-D 
diffusion problem is:  
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where C(x, y, t) is the concentration.  The diffusion coefficients (D1 and D2) in each 
region are again assumed independent of concentration or position.  The EGF was 
initially located in region 1 with uniform concentration and diffused out toward the entire 
area with different diffusion rate in each layer. Diffusion in water-like media is expected 
to be higher than that in the gel layer. No diffusion flux into the wall was imposed as the 
wall boundary condition. The interfacial boundary condition was such that the 
concentration and diffusion flux are continuous across the interface. The diffusion 
coefficient of EGF in cell culture medium was again obtained via Young’s approximation 
and calculated to be 1.69x10-6 cm2/s in the media region. Due to the lack of available 
information about Matrigel material properties (e.g. viscosity), we were unable to apply 
Young’s equation to determine the diffusion coefficient in Matrigel.  Nauman et al in a 
recent paper utilized a fluorescent-based method to determine the diffusion coefficient of 
insulin growth factor (IGF-1) and Ribonuclease in a 200 µm layer Fibrin hydrogel [10].  
The experimentally determined diffusion coefficients agreed with previously reported 
values for the two proteins; however, it was suggested that the gel network had a 
negligible effect on the diffusion coefficient. We believe that Matrigel has a more 
complex gel structure than fibrin due the presence of various proteins and, this gel 
structure will have an important effect on diffusion.   
In order to solve equation 4-4, we assumed various diffusion coefficients for EGF 
in the Matrigel layer as a certain percentage of the diffusion coefficient in the media 
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region.  Comsol Multi-physics software was then used to solve the dual layer case and 
obtain concentration profiles of EGF throughout the microchannel. 
  
 
4.3 Result and Discussion 
The aim of this study was to give an explanation for the MDA-MB-231 cell 
growth profile observed on micropatterned Matrigel tracks after 4 days of cultivation in a 
microfluidic channel.  The analysis of microenvironmental conditions such as the 
imposed concentration gradient influencing the directed movement of the cells was 
determined based on the experimentally obtained data showing cell migration kinetics 
[12].  We initially started with a simple 1 layer approximation to define the concentration 
profiles of EGF present within the microchannel.  One of the first considerations for these 
types of studies is to determine an appropriate diffusion coefficient for EGF.  Fortunately, 
Young developed a correlation for estimating the diffusion coefficients of various 
proteins molecules based on molecular weight provided that the partial specific volume 
of the protein is between a specified range of 0.69 and 0.78 cm3/g [8].  The partial 
specific volume of EGF is 0.71 cm3/g, which fall within the specified range.  Based on 
this information, we were able to plot concentration profiles of EGF in the microchannel 
media domain using the single layer model (Figure 4-4). 
  
120
 
Figure 4-4. The normalized EGF concentration profile along the middle line of cell culture medium 
(Figure 4-2.)  over a 5 day period 
 
To our knowledge, no equation for diffusion in Matrigel has ever been developed.  
It is possible that the diffusion behavior in Matrigel does not follow the Fick’s law 
because of the complex structure of gel state. However, a qualitative analysis can be 
started by assuming Fick’s law for diffusion in Matrigel. Considering the gel state has a 
high viscosity, it is likely to pick smaller diffusion coefficients in a gel than in the water-
like medium. By selecting various diffusion coefficients of EGF in Matrigel, the diffusion 
of EGF concentration was simulated with COMSOL software. Figure 4-5 shows 
concentration profiles along the middle line of the culture medium after 1 day from EGF 
injection time. It shows that the profiles of chemical for 2-layer cases are somewhat close 
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to each other while the 1-layer simplification (neglecting Matrigel layer) result is quite 
different from the rest.  
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Figure 4-5.  The normalized EGF concentration profile along the middle line of cell culture medium 
(Figure 4-3.) after 1 day diffusion. D1 and D2 indicate the diffusion coefficients in the top and bottom 
layers respectively. 
 
As mentioned previously, the 2-layer model is probably a better representation of 
the real case due to the swelling properties of Matrigel.  Notice that the tested diffusion 
coefficient for D2 varies in the range of 100 times difference compared to D1. The reason 
for small variation of diffusion pattern with large range of diffusion coefficient is that the 
diffusion length in y direction (Figure 4-3) is much smaller than that in x direction. In 
other words, y directional chemical gradient diffuses fast to a uniform profile while x 
directional diffusion is relatively slow.  Figure 4-5 shows that 1 layer chemical 
distribution is very close to twice of D2 = D1 case also with the reason mentioned above. 
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Since D1 is higher than D2, diffusion in layer1 is faster than that in layer2. As the 
diffusion in the top layer exceeds the diffusion in the bottom layer, a concentration 
gradient is generated in y direction. However, the gradient of concentration in y direction 
is quickly adjusted due to the formerly mentioned reason. Thus, the whole diffusion 
behavior of this problem is mainly controlled by faster diffusion coefficient, D1.  
 
Figure 4-6. Concentration of EGF along the middle line of cell culture medium. D1=1.69x10-6 cm2/s and 
D2= 1.69x10-7 cm2/s. 
 
Since no diffusion information about Matrigel is known, we selected D2=0.1 D1 
for analysis. Again, because of the diffusion feature of the high aspect ratio 2-layer 
problem, inaccuracy of the slower diffusion coefficient may not cause a significant error 
in the results. Figure 4-6 shows the temporal variation of EGF in 2 layer geometry under 
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above mentioned conditions. After 4 days, the chemical is diffused to almost uniform 
profile. 
The cell migration rate is related to the gradient of the chemoattractant. The 
higher gradient may induce higher migration rate. The cell migration behavior is a 
complicated phenomena involving numerous cellular activities and chemical responses to 
the environment. However, a formula can be attempted to relate cell migration with the 
gradient of chemoattractant. The following formula is suggested for a simple modeling of 
the relationship between cell migration rate and chemical gradient in 1 D case. 
 
b
dx
dcav ⎟⎠
⎞⎜⎝
⎛=      (5) 
 
where v is cell migration rate and dc/dx is concentration gradient at the cell location. 
Since the cell location varies as the cell migrates towards the chemoattractant, a 
numerical integration is needed for migration analysis. By trial and error, we found that 
the following values for a and b in equation (4-5) bring the migration distances obtained 
close to the ones measured experimentally in Table 3-1 (505 μm with 25 ng/ml, 1592 μm 
with 50 ng/ml). 
a = 0.002418 and b = 0.6854 
 
The parameter b is less than 1, which means that cell migration rate does not increase as 
fast as the gradient increases. It is more likely than linear proportionality. Figure 4-7 
shows the transient migration simulation by using Eq (4-5) with the selected parameters. 
For the first day, the cell migration was slow because the chemical did not diffuse much 
up to the cell location. This also agrees well with what we observed in the experiment. 
We also tested the obtained formula for another geometry, which has 5mm length and 
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injected chemical concentration, 50 ng/ml. The average observed migration distance was 
812 μm while the numerically simulated migration distance using formula (4-5) was 
825 μm. The numerical and experimental results show a significant agreement for tested 
cases.  
 
 
Figure 4-7. Migration of cell with time. The cell location varies with Eq (4-5). 
 
4.4 Limitations of Numerical Modeling 
Cell migration is a very complicated biological process that requires a 
coordination of both biochemical signaling pathways and physical locomotory processes.  
The modeling of cell migration mechanisms requires an in-depth understanding of 
cellular interactions with the extracellular matrix and the physiochemical 
microenvironment.  Numerical modeling approaches provide a way for us to begin to 
integrate these processes in a more physiologically relevant manner. While our long-term 
goal is to develop a complete physiochemical model of cell migration within our devices, 
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our initial attempt took a simplified approach that accounts for the relationship between 
the cell and the chemical gradients generated within the microenvironment.  Based on 
this approach, we were able to define the concentration profiles within the microchannel 
and developed a mathematical relationship between cell migration and the generated 
gradients. 
However, this modeling approach adopted many simplifications so that further 
verification may be required.  The arbitrarily determined values for a and b does not take 
into consideration important biological parameters such as cell-matrix interactions that 
affect migration rates.  Also, the reaction kinetics that guides cell receptor distribution for 
EGF was not included in this modeling.  In the future, this modeling approach should 
provide a more comprehensive physio-chemical model that accounts for the various 
individual biophysical and biochemical processes involved in cell motility such as cell 
membrane (lamellipodia extension), formation of cell/matrix attachments, cell receptor-
ligand kinetics, force transmission to the cell/matrix, and random cell motion 
(chemokinesis) [11]. 
 
 
 
4.5 Conclusion 
In this study, we considered a mathematical model of cancer cell migration on a 
tissue like matrix, which focuses on the response of single MDA-MB-231 cells to a 
concentration gradient of EGF.  The domains of interest consist of a water-like medium 
layer and a Matrigel layer.  The diffusion of EGF concentration throughout both domains 
was solved by a finite element method.  The diffusion coefficient of EGF in medium was 
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calculated using a previously developed empirical formula, while that in Matrigel layer 
was estimated after a careful study of the characteristics of thin two-layer diffusion 
problem.  An empirical relationship between the cell migration rate and the growth factor 
gradient was established based on previous experimental results obtained by our group.  
The cell migration was then numerically calculated from the modeled cell migration rate.  
The cell migration results obtained from the numerical computations showed an 
agreement with experimental results.   
The analytical model developed here can help to predict cell migration velocity 
under various biochemical gradients.  In the future, we will consider the kinetics of the 
EGF ligand-receptor kinetics.  We may need to adopt a more complicated 2-D 
convection-diffusion equation model that incorporates a reaction rate term so that we can 
properly model the chemical kinetics.  Also, since cells are known to migrate randomly in 
the presence of growth factor gradients (Chemokinesis) [11], we may need to incorporate 
a probability model to account for this random cell motion. 
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CHAPTER 5. “LIVER ON A CHIP” – ENGINEERING THE HEPATIC 
SINUSOID (A LAYERED CO-CULTURE MODEL) 
5.1 Introduction 
The liver is the solid largest organ in the body and performs a plethora of 
regulatory and metabolic activities for the body [1, 14-15].  Liver activities include 
regulation of blood-glucose levels, bile synthesis, and production of blood-related 
proteins such as albumin [15].  The liver receives oxygen-rich blood from the hepatic 
artery and nutrient-rich blood from the portal vein [15].  This dual blood supply exposes 
the liver to ingested materials (e.g. nutrients, drugs, etc.) as well as toxins and infectious 
agents [8].  As a result, another important function of the liver is as a detoxification unit.  
The liver’s role in drug metabolism and detoxification is an important subject in 
pharmaceutical research of drug compounds as most drugs fail due to direct toxicity to 
the liver [8].  Therefore, a detailed understanding of the mechanisms governing liver 
biology and drug induced liver pathogenesis would be beneficial from both a clinical and 
investigational perspective. 
Current liver systems include animal models, liver tissue samples, cell lines, and 
primary hepatocytes [15].  Whole animal models are complex and it is very difficult to 
trace molecular pathways experimentally [8,15].  Although, human liver tissue samples 
represent a physiologically relevant system for studying liver biology, they have limited 
viability and quantities of healthy samples are difficult to obtain [1-5].  In vitro liver 
models such as hepatocarcinoma cell lines and immortalized hepatocytes can be 
reproducible; however, they display abnormal levels of liver-specific functions and have 
questionable biological relevance [4-10].  Of all these systems, primary hepatocytes are 
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the most beneficial as they offer the convenience of simplicity compared to animal 
models, while still maintaining a biologically relevant context.  However, these 
parenchymal cells are extremely difficult to maintain in vitro [8].  Once enzymatically 
isolated from the liver and cultured in monolayers, they rapidly lose normal liver 
morphology and differentiated functions [1-2].  In addition to the loss of normal liver 
functions, the decline in hepatocyte viability is also a hindering factor in liver biology 
research. 
The growth limitations of primary hepatoctyes as well as the loss of cellular 
functions have resulted in growing efforts to develop new in vitro culture models for 
hepatocytes.  Many researchers have looked to the microarchitecture of the liver to 
provide inspiration for new cell culture platforms in an attempt to replace the lost signals 
from the native hepatocyte microenvironment.  Some examples include co-cultivation of 
hepatocytes with other cell types such as fibroblasts or established endothelial cell lines 
[9, 11-13].  Others have developed microfluidic bioreactor systems that mimic the liver 
mass transport [14].  Unfortunately, none of these systems entirely recreate the 
microenvironmental architecture of the liver and therefore, cannot fully capture both the 
structural and functional aspects of the liver.  The lack of normal liver architecture likely 
impacts hepatocyte physiology.  Therefore, there is a need for innovative, experimentally 
tractable liver models that recreates the normal environment and cellular composition of 
the native liver. 
In this study, we present a novel model system that recreates the basic functional 
unit of the liver – the hepatic sinusoid.  The liver is a well organized, three-dimensional 
structure containing four different vasculatures: the portal vein, the hepatic artery, the 
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hepatic sinusoid, and the hepatic vein (Figure 5-1).  The hepatic sinusoid is a specific 
capillary network system that facilitates the exchange of essential metabolic substances 
between the in coming blood stream and the hepatic parenchymal cells [15-16].  
Therefore, it is considered to play an important role in maintaining liver function.  This 
basic functional unit of the liver (Figure 5-2) is composed of hepatocytes, the primary 
cell type of the liver circumscribed by a layer of liver sinusoidal endothelial cells.  Other 
significant resident cell types include Kupffer cells (local macrophages) and stellate cells 
that secrete matrix proteins. 
 
 
 
Figure 5-1.  The liver sinusoid and surrounding cells, a functional liver unit (upper left picture).  Blood 
flows from portal vein to central vein. (Adapted from www.akaike-lab.bio.titich.ac.jp) 
 
 
The endothelium serves as a permeable membrane for the exchange of nutrients 
and compounds, while preventing the direct exposure of hepatocytes to the fluid flow.  
We believe that recreating this basic structure of the liver is the key to retaining normal 
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hepatocyte physiology for long-terms.  In a similar fashion, our unique platform is 
composed of microfabricated channels housing monolayers of primary rat hepatocytes 
(PRH) and primary rat liver sinusoidal endothelial cells (LSEC) or a rat adrenal 
medullary endothelial cell line (RAMEC) separated by Matrigel (Figure 5-2).   The 
RAMEC cells were used in our initial proof of concept experiments since they were more 
readily available.  Matrigel was placed in between the two cells in order to mimic the 
space of disse.  The microchannels then create a fluidic housing over the cells mimicking 
both the sinusoidal architecture and cellular composition.   
 
 
Figure 5-2.  Schematic representation of the microfluidic platform mimicking the hepatic sinusoid 
 
In this layered configuration, PRH retained their normal hexagonal morphology 
and remained viable for over 30 days.  To verify viability of the PRH, we used 
adenoviruses containing the green fluorescent protein (GFP) to fluorescently label viable 
hepatocytes.  As a control, endothelial cells alone were incubated with Ad-GFP and 
similar to previous reports, we confirmed that adenoviruses do not infect endothelial cells 
so the only cells that express GFP are hepatocytes [24].   In addition, hepatocytes 
cultivated in this configuration retained long-term expression of CYP2E1 (an enzyme 
responsible for ethanol metabolism), while hepatocytes cultured in the absence of the 
Configuration 
Hepatocytes 
Endothelial Cells
Matrigel
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endothelial cells did not survive long enough to retain CYP2E1 expression.  We believe 
that this work can provide the preliminary basis for conducting various experiments 
utilizing primary hepatocytes of human origin since only a small number of cells are 
required for studies in this microchannel.  The long-term use of this system could include 
studies to understand the impact of various infectious agents/toxins on hepatocytes 
utilizing a more physiologically relevant system. 
 
5.2 Materials and Methods 
Device Fabrication and Preparation: 
Rectangular microchannels were made from PDMS using a photolithographically 
defined template (Figure 5-3).  Each microchannel was 1 cm long and 100 μm high with 
a width of 1000 μm.  Negative photoresist, SU-8 2035 (Microchem Corporation) was 
spun onto a 2 inch x 2 inch borosilicate glass at an initial speed of 500 rpm at 100 rpm/s 
for 10 seconds followed by additional spinning at 1400rpm – 300 rpm/s for 30 seconds.  
Soft baking of photoresist was achieved on a hot plate at 65ºC for 5 minutes and at 95ºC 
for 20 minutes.  UV exposure through a chrome mask was performed with approximately 
500 mJ/cm2 of energy.  Post exposure baking on a hot plate at 65ºC for 1 minute and at 
95ºC for 10 minutes was followed by development in SU-8 developer (Microchem 
Corporation) and cleaning in isopropanol.  The fabrication process yielded channels with 
a height of 100 µm on average over the entire channel length.   
Once the photoresist template was fabricated, it was placed in a 3-inch plastic dish 
for standard PDMS replica molding.  PDMS (Sylgard 184, Dow Corning Corporation) 
was prepared in a 10:1 (prepolymer:curing agent) ratio, cast as desired, degassed to 
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remove air bubbles and then cured at 80ºC in a convective oven for 1 hour.  After cooling 
to room temperature, the PDMS membrane was peeled off the mold, cut down to size and 
a sharp stainless steel metal tubing (0.02-inch inner diameter) was used to core holes 
through the PDMS to access the channels.  The PDMS membrane was then placed 
directly into a culture dish until it was ready for use.  Sterilization of the microhannels 
was achieved by placing them in 70% ethanol for 5 minutes.  This step was followed by 
placing the device in a sterile cell-culture hood under a 15 minute UV treatment.  The 
microchannels were then brought in direct contact with collagen-coated tissue culture 
dishes, and the interfacial property of PDMS allowed it to stick reversibly to the bottom 
of the dish.   
 
 
 
Figure 5-3.  Schematic representation of the microchannel fabrication process 
 
Primary Liver Cell Isolation and Culture: 
Photoresist coating Mask Alignment/UV Exposure 
PDMS Micromolding Membrane Release 
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Primary rat hepatocytes (PRH) were isolated from 6-12 weeks old Sprague-
Dawley rats as previously described [17].  The rat hepatocytes were prepared by a 2-step 
perfusion method using calcium-free buffer to disrupt hepatocyte desmosomes, followed 
by perfusion with collagenase-containing buffer to separate hepatocytes from the 
extracellular matrices.  The liver was removed and hepatocytes are sedimented over 
Percoll and plated on collagen coated dishes.  Following hepatocyte isolation, the 
remaining supernatant is further purified to remove additional parenchymal cells [23].  
The remaining non-parenchymal cells were obtained from the supernatant after a 7 
minutes, 350G centrifugation.  Cells are resuspended in 20ml of Williams E Medium 
(WEM) and loaded onto a 25%/50% Percoll density gradient (See Table 5-1 for Percoll 
recipe).  After 20 minutes of a 900G centrifugation, cells located at the interface and just 
below the interface were collected and resuspended in WEM.  The cell pellet after a 10 
minutes 350G centrifugation step was used as the sinusoidal endothelial cell (LSEC) 
fraction.  Both the primary hepatocytes and sinusoidal endothelial cells were maintained 
in hepatocytes growth medium. 
 
Rat Adrenal Medullary Endothelial Cell (RAMEC) Culture: 
Rat adrenal medullary endothelial cells were obtained from the Tissue 
Engineering and Regenerative Medicine Laboratory (courtesy of Dr. Peter Lelkes) and 
cultured on collagen-coated 10-cm-diameter tissue culture plates in Minimal Essential 
Medium (MEM) supplemented with 10% fetal bovine serum, nonessential amino acids, 1 
mM sodium pyruvate, 2mM L-glutamine, and 5µg of gentamicin per ml.  Cells were 
maintained in incubators at 37ºC in 5% CO2 and medium was replaced every 2-3 days.   
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Layered Co-culture of Primary Rat Hepatocytes and Endothelial Cells: 
Primary rat hepatocytes were introduced into the microchannels as previously 
described [17].  To create layered co-culture of PRH with liver sinusoidal endothelial 
cells, first we inoculated the microchannels with 20 µl of PRH suspension and allowed 
the cells to adhere for approximately 3 hours while we isolated the LSECs.  LSECs were 
resuspended in approximately 150 µl of growth medium containing 30% (v/v) growth-
factor reduced Matrigel (BD Biosciences).  The cell suspension (~ 20 µl) was then 
delivered gently into the microchannels containing the PRH cells and then placed in an 
incubator.  For the layered co-culture of PRH with RAMEC cells, we first cultured PRH 
in microchannels for 48 hours to allow the cells to form a complete monolayer with 
adequate tight junctions.  A plate of confluent RAMEC cells was trypsinized to detach 
the cells from the plate and resuspended in 300 µl of growth medium containing 30% of 
Matrigel.  The RAMEC cell suspension (~ 20 µl) was then delivered into the 
microchannels containing PRH cells.  Cells were maintained in incubators at 37ºC in 5% 
CO2 and growth medium was replaced every day. 
 
Table 5-1. Percoll density gradient recipe 
 
Materials 25% 50% 
   
10x Phosphate Buffer 0.9 ml 0.9 ml 
   
Percoll 7.5 ml 15 ml 
   
Williams E Medium 15.6 ml 8.1 ml 
   
Bovine Calf Serum 6.0 ml 6.0 ml 
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RT-PCR Analysis of Liver Specific Markers 
 Reverse transcription-polymerase chain reaction (RT-PCR) analysis was used to 
identify mRNA transcripts in primary rat hepatocytes and liver sinusoidal endothelial 
cells cultured in microchannels as previously described [17].  Briefly, total RNA from 
hepatocytes and endothelial cells was prepared by using TRIzol Reagent (Invitrogen, Life 
Technologies, USA) according to the manufacturer’s directions. A one-step RT-PCR kit 
(Bio-Rad) was used for the reaction, in which RNA was reverse transcribed in a 
Thermocycler (Eppendorf) using the following program: 5 min at 25˚C followed by 30 
min at 42˚C and 5 min at 85˚C.   Several transcription factors have been identified in the 
liver as being important for the differentiation of liver parenchymal cells including 
hepatocyte nuclear factor 4 (HNF-4), transferrin (TFN), and albumin (ALB) [18].   
Endothelial cells including sinusoidal endothelial cells express differentiated markers 
such as vascular endothelial growth factor (VEGF) receptors KDR and FLT [19].  They 
have also been shown to express vascular cell adhesion molecule 1 (VCAM-1) [20].  The 
gene-specific primers for these transcripts are listed in Table 5-2.  PCR controls to detect 
contamination consisted of original isolated RNA not reverse-transcribed and a water 
control was interspersed between samples.  The amplified product was electrophoresed 
on a 1.5% agarose gel.  Bands of the appropriate size were visualized under UV light 
after ethidium bromide staining.  Each sample was analyzed and read as positive or 
negative.  Positive and negative controls were run in parallel with our assay. 
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Table 5-2. Sequences of reverse-transcriptase polymerase chain reaction primers to 
identify rat liver specific mRNA transcripts. 
Primer Sequence (5’-3’) Size, 
bp 
Cycle 
    
Albumin GCCGAAAACTGTGACAAGTC 914 30 
 TCTCGTAAAGCTCACAGTTAG   
HNF-4 CGGGCCACTGGCAAACAC 770 30 
 GTAATCCTCCAGGCTCACC   
Transferrin GGCTCAGGAACACTTTGGC 530 30 
 GTTGTTCCAGTTGATGCTGG   
Flt-1 ACCTCAGTGACCACGAGGTGTCC 250 30 
 TGCACGGTGAGGTACGCTGAGC   
VCAM-1 AGAACGGGGGAACTGCAGCCTC 335 30 
 TGCAGCTGTGCCTTGCGGATGGTG   
Kdr TTGGTGATGAACTCACCATCATGG 259 30 
 GCTTCTTCTAGCTGCCAGTACC   
 
 
Western Analysis for CYP2E1 Expression 
 The co-cultured hepatocytes and RAMEC cells were scraped and washed twice 
with PBS, then homogenized in a lysis buffer (8% SDS, 240mM Tris pH 6.8, 40% 
Glycerin, 0.02% Bromophenol blue).d.  Samples (100 μg) were separated on a 12.5% 
sodium dodecyl sulfate (SDS)-polyacrylamide gel, and transferred onto a nitrocellulose 
membrane (Bio-Rad Laboratories, Munich, Germany). Nonspecific binding sites were 
blocked by incubating the membranes at 4 °C in 5% nonfat milk solution. After washing 
with PBS/Tween-20, membranes were incubated with a rabbit CYP2E1 polyclonal 
antibody (1:1000 dilution, Abcam) and monoclonal mouse anti-β-actin antibody (1:1000, 
Sigma) at room temperature for 1.5 h.  Using secondary antibody IRDye® 800 CW 
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conjugated goat anti-rabbit (1:5000, Li-COR) and Alexa Fluro® 680 anti-mouse antibody 
(1:5000, Molecular Probes), the protein CYP2E1 and β-actin were detected by Odyssey 
Infrared Imaging Systems.  
Adenoviral Infection of Primary Rat Hepatocytes. 
 Recombinant adenoviruses were created using the AdEasy system (Stratagene) 
according to the manufacturer’s directions (Bouchard; unpublished data).  The gene 
encoding GFP was also cloned into the recombinant adenovirus (AdGFP) to allow us to 
visualize viable hepatocytes using a fluorescent microscope.  High titer recombinant 
adenovirus stocks were prepared as previously described [17].  Briefly, the recombinant 
adenoviruses were amplified in HEK 293 cells and high titer stocks were used for 
infection of PRH.  Cells were infected with the recombinant adenovirus at 80% 30 days 
after plating.  Virus stock aliquots containing the appropriate number of PFU to obtain 
the desired multiplicity of infection (MOI) were mixed with 20 μl of PRH media and 
added to cells.  After 1 hour at 37ºC, additional PRH medium was added to the 
microchannels.  Culture media was changed daily for the duration of the experiment.  
PRH expressing GFP was visualized using a Nikon fluorescent microscope.   
 
5.3 Results and Discussions 
Primary Cell Culture in Microchannel 
 We successfully cultured both primary rat hepatocytes and primary liver 
sinusoidal endothelial cells in our microchannels.  Figure 5-4  shows pictures of primary 
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rat hepatocytes and LSECs cultured in the microchannels for 4 days.  As can be seen 
from these pictures, cells displayed normal morphologies and remained viable within the 
microchannel environment.  Since it was our first time isolating primary LSEC, we 
wanted to compare the morphology of the isolated cells to a known endothelial cell line.  
As can be seen in Figure 5-5, the isolated LSECs were morphologically similar to the 
RAMEC cells and contamination with other cell types was not apparent.   
 
 
 
 
 
 
 
 
Figure 5-4.  Primary Cell Culture in Microchannel. (a) shows primary rat hepatocytes cultured in 
microchannels and panel (b) shows liver sinusoidal endothelial cells cultured in microchannels. Scale bar: 
50 μm 
 
 
 
Figure 5-5.  Comparison of LSEC morphology with an established endothelial cell line (RAMEC) 
 
 
LSEC RAMEC
(a) (b)
Hepatocytes LSECs 
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In addition to comparing the morphology of isolated cells with known endothelial 
cell lines, we also checked for endothelial cell specific markers.  The differentiated 
functional attributes of primary liver cells are facilitated and maintained through the 
coordination of a series of liver proteins [17-20].  In order to ensure that cells cultured in 
our system retained their liver specific phenotype, we performed RT-PCR to identify 
liver specific mRNA transcripts in cells cultivated in our microchannels.  RT-PCR 
revealed that for the duration of all experiments, PRH expressed known hepatic markers 
such as transferrin, hepatocytes nuclear factor 4, and albumin (Figure 5-6a,b), while 
LSECs expressed known endothelial cell markers such as vascular endothelial growth 
factor receptors KDR and FLT-1, as well as vascular cell adhesion molecule 1 (Figure 
5-6c). 
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Figure 5-6. Confirmation of primary hepatocyte and liver sinusoidal endothelial cell differentiation in 
microchannel culture. (a,b) Freshly isolated primary rat hepatocytes and PRH cultured in microchannels for 
four days expressed mRNA transcripts such as Transferrin (530bp), Albumin, (914bp) and Hepatocytes 
nuclear factor 4 (770bp). (c) Liver sinusoidal endothelial cells cultured in microchannels also expressed 
endothelial cell markers such as Vascular endothelial growth factor receptors (KDR (259bp) and Flt-1 
(250bp)) and vascular cell adhesion molecule 1 (335bp). 
 
 
Layered Co-Culture in Microchannels 
 Our goal was to develop a microfabricated platform housing the two primary liver 
cells (hepatocytes and sinusoidal endothelial cells).  Because we isolate both the 
hepatocytes and LSECs on the same day, we were unable to achieve a layered co-culture 
of PRH with LSECS.  PRH require at least 48 hours in order to form a complete 
monolayer.  The 3-hour window between plating the LSECS over the PRH is not 
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sufficient for the hepatocytes to form a monolayer, so we observed that the LSECs settled 
in regions in between the hepatocytes (Figure 5-7).  Although the cells were not in the 
configuration we wanted, both hepatocytes and LSECs remained viable for at least 10 
days.  This problem can be solved by isolating the cells on different days. 
 
 
 
Figure 5-7.  Attempt to co-culture primary hepatocytes (PRH) and liver sinusoidal endothelial cells in a 
layered configuration.  At day 2 the endothelial cells were sitting in between regions of hepatocytes and by 
Day 7, the endothelial cells grew larger and occupied a bigger region near the hepatocytes. 
 
 
In order to successfully layer the two cell types, we developed protocols to 
construct a dual layer of primary rat hepatocytes and an established endothelial cell line, 
RAMEC (Figure 5-8).  RAMEC cells are an established microvascular endothelial cell 
line derived from the rat adrenal medulla [22].  We used RAMEC cells because they can 
be passaged and are more readily available.  With the RAMEC cells, we were able to 
create two separate monolayers of cells separated by Matrigel.  RAMEC cells were 
diluted in Matrigel-Media solution.   
 
PRH + LSEC  PRH + LSEC  
Day 2 Day 5 
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Figure 5-8. Primary rat hepatocytes and rat adrenal medullary endothelial cells co-cultured in a layered 
configuration.  Hepatocytes were initially seeded into the microchannels.  After 48 hours, the RAMEC cells 
were introduced into the microchannels.  Following 72 hours, the two cell types formed separate 
monolayers. 
 
 
The layered configuration was verified using a phase contrast microscope.  When 
the RAMEC cells were in focus, the hepatocytes were not and similarly, when the PRH 
were in focus, the RAMEC cells were not.  In this layered configuration, PRH cells 
retained their normal morphology and remained viable for more than 30 days (Figure 
5-9).  In contrast, PRH cells cultivated in the absence of the endothelial cells did not 
retain their morphology and actually developed large vacuole spacing that eventually 
resulted in cell death at around 6 days following plating (Figure 5-10).  In order to verify 
viability of the PRH co-cultured with RAMEC, we used adenoviruses that were cloned 
Configuration 
Hepatocytes
RAMEC
Matrigel
Configuration 
Hepatocytes 
Configuration 
Hepatocytes
RAMEC
Matrigel
Hepatocytes (PRH) 48 hrs after seeding 
Channel with RAMEC just after seeding 
Both Cells 72 hrs after RAMEC seeding 
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RAMEC PRH 
Ad-GFP Positive PRH 
Panel represent same cells
(a) (b) 
Day 30 Day 30 
with GFP to infect primary hepatocytes.  We have verified and confirmed that 
adenoviruses do not infect endothelial cells so the only cells that express GFP are the 
hepatocytes (data not shown). 
 
Figure 5-9.  Long-term culture of primary rat hepatocytes (PRH) and rat adrenal medullary endothelial 
cells in layered configuration.  PRH co-cultivated with RAMEC cells remained viable for 30 days as 
verified by GFP expression by viable cells (right panel). 
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Figure 5-10. Comparison of a layered co-culture of primary hepatocytes and RAMEC cells (top row) with 
a homotypic culture with primary hepatocytes only (bottom row).  PRH cells cultured alone starts to form 
large vacuole spacing that eventually leads to cell death. Scale bar: 100 μm 
 
Long-term expression of CYP2E1 in layered co-culture 
Cytochrome P-450 (CYP2E1), an ethanol-inducible form of CYP, is of interest 
because of its ability to metabolize and activate many important substrates such as 
ethanol, drugs, and toxins [21].  We investigated the long-term expression of CYP2E1 in 
primary rat hepatocytes over 14-day culture period.   As can be seen from the western 
blot analysis (Figure 5-11), CYP2E1 expression levels remained relatively similar up to 
day 10.  However, we observed a relatively lower expression level of CYP2E1 at day 14 
compared to the β-actin positive control.  This reduction in the protein expression may be 
PRH Only Day 2 PRH + RAMEC Day 7 
PRH Only Day 2 PRH Only Day 7 
Hepatocytes Co-cultured with RAMEC 
Hepatocytes Cultured Alone 
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related to decreased cell viability.  Moreover, since the hepatocytes were co-cultivated 
with RAMEC cells, this effect may be due to some long-term influence of the RAMEC 
cells on the hepatocytes or overgrowth of culture by RAMEC. 
 
 
 
Figure 5-11. Long-term expression of CYP2E1 (an ethanol metabolizing enzyme) protein by primary 
hepatocytes co-cultured with RAMEC cells.  PRH retained expression of CYP2E1 for 14 days. 
 
 
5.4 Conclusion 
We have successfully demonstrated a layered co-culture of primary rat 
hepatocytes with an endothelial cell line.  Primary hepatocytes cultivated in our 
microchannel platform retained normal morphology and remained viable for more than 
30 days.  In addition, hepatocytes cultivated in this configuration retained long-term 
expression of CYP2E1 (an enzyme responsible for ethanol metabolism).  We believe that 
this work can provide the preliminary basis for conducting various experiments utilizing 
primary hepatocytes of human origin since only a small number of cells are required for 
studies in this microchannel.  The long-term use of this system could include studies to 
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understand the impact of various infectious agents/toxins on hepatocytes utilizing a more 
physiologically relevant system. 
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CHAPTER 6.  MICROFLUIDIC PLATFORM FOR HEPATITIS B VIRAL 
REPLICATION STUDIES 
 
6.1 Introduction 
Chronic infection of the liver with the human hepatitis B virus (HBV) has been 
associated with the development of primary liver cancer, hepatocellular carcinomas 
(HCC) [1-3].  With an estimated 350 million people chronically infected with the virus 
worldwide [2], it is important to understand the process by which persistent HBV 
infection is maintained and linked to the development of liver cancer.  One approach to 
studying HBV-associated liver cancer is to understand the mechanism of HBV 
replication and to identify viral genetic factors associated with liver pathogenesis.  HBV 
is a member of the hepadnaviridae family of small-enveloped DNA viruses that replicate 
mainly in the livers of their hosts [2].  HBV also encodes several proteins that promote 
viral replication and contribute to the development of HCC [1, 4-5].  While the 
development of HCC likely involves a complex interplay between host hepatocytes and 
viral genetic factors, available systems mainly rely on the use of established cell lines or 
animal models.  Established cell lines and animal models are either not physiological, or 
too complex to trace molecular processes and pathways involved in the development of 
liver diseases; thus, necessitating an innovative approach to conducting cell-based studies 
in an appropriate context while performing cellular/genetic manipulations in a more 
controlled manner [2,6].   
Hepatocytes, the cells responsible for the metabolic and detoxification processes 
in the liver, are the predominant target of hepadnaviruses infection and serve as an 
appropriate in vitro cell-culture model for studying HBV replication [7-9].  Upon entry of 
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HBV into host hepatocyte, the virus’ partially double-stranded DNA genome is 
translocated to the cell nucleus, where it is converted into a covalently-closed circular 
DNA form, from which viral mRNAs are transcribed [2].  One of these viral transcripts, 
the pregenomic RNA, serves as a template for replication.  The pregenomic transcript in 
association with viral polymerase/reverse transcriptase is packaged into nucleocapsids 
that can then be enveloped and secreted from cells [5].  Unfortunately, the use of primary 
human hepatocytes as physiologically relevant models for liver research is hampered by 
the limited availability of normal human liver cells [10-11].  Human liver cells are 
typically derived from surgically removed, diseased livers and large quantities of healthy 
human hepatocytes are difficult to obtain; thus, there is a need for innovative, 
experimentally tractable models such as miniaturized cell culture systems that can serve 
as a platform for studying the effect of HBV infections on hepatocyte physiology.  
Besides requiring only a small number of hepatocytes for studies in micro chambers, 
reagents and other biochemicals used are reduced as well. 
Microfabrication technologies have enabled researchers to design and build 
micro-scale cell culture systems with the capability to perform biological based 
experiments in a controlled environment that is reminiscent of the native surrounding of 
cells in vivo [12-14].  These systems have critical dimensions similar to cells and are well 
suited for introducing functionalities to various substrates.  Several groups have 
developed microfluidic systems to demonstrate the importance and physiological 
relevance of micro scale cell culture in basic cellular and cancer biology [15-19].  
Besides addressing the biocompatibility and adequate nutrient supply issues in 
microfluidic devices, these studies were also successful in maintaining the 
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physiochemical and physiological environment in which cells are cultivated and 
manipulated in vitro.  As an example, Glasgow et al observed in vivo growth and 
proliferation rates when mouse embryonic cells were cultured in elastomeric 
microchannels [20].  Microdevices have also been designed for continuous perfusion and 
long-term monitoring of mammary [21] and muscle cells [17].  Genetic information have 
also been delivered into cells housed in microchannels using techniques such as 
electroporation [22] and viral-mediated infection using laminar focusing technique [23]. 
This chapter describes a simple microchannel cell-culture based assay for 
studying HBV replication.  Polydimethylsiloxane (PDMS) microchannels were fabricated 
using soft lithography techniques and served as culture platforms for studying HBV 
replication in HepG2 cells, a human hepatoblastoma cell line, and primary rat 
hepatocytes (PRH).  Traditional macro-scale systems have used cultures of PRH and 
HepG2 cells as in vitro model systems for HBV replication studies.  The use of PRH as a 
model is advantageous because replication assays can be performed in normal 
hepatocytes, a biologically relevant context.  Moreover, using hepatocytes isolated from 
genetically identical rats provides consistency and eliminates the diversity that may be 
found from human samples.  Currently, there is no established cell line that allows for 
direct HBV infection, presumably due to the lack of HBV receptor.  Likewise, direct 
infection of primary rat hepatocytes with HBV is not possible due to the species 
specificity of hepadnaviruses.  These restrictions are circumvented by using other 
methods such as lipid-mediated transfection [24] and HBV-recombinant adenovirus 
infection in macro-scale replication studies [25].   
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In order to test the feasibility of conducting viral replication assays in a 
microfluidic chamber, we first demonstrated that our microchannels were capable of 
supporting the normal cultivation of both HepG2 cells and PRH.  Although methods such 
as electroporation have been used to deliver genetic material into cells cultured in 
microchannels, this technique requires the use of specialized equipment and is not 
compatible with all cell types.  In addition, the use of high voltages necessary for creating 
pores in the cell membrane often results in cell death.  In our studies, we used cationic 
lipids and recombinant adenoviruses to facilitate delivery of HBV genome into both 
HepG2 cells and PRH respectively.  We achieved approximately 40% and 10% 
transfection efficiencies in HepG2 cells and PRH respectively, and 80 – 100% adenoviral 
infection efficiency in PRH comparable to standard tissue culture methods.  To our 
knowledge, this is the first demonstration of HBV replication assays in hepatocytes 
cultivated using microchannels.  HBV DNA secreted from transfected or infected cells 
was isolated and detected using polymerase chain reaction (PCR).  We believe that this 
work can provide the preliminary basis for conducting HBV studies in a microfluidic 
channel and can be easily extended to studies involving primary human hepatocytes since 
only a small number of cells are required for studies in microfluidic chambers.  
 
6.2 Materials and Methods 
Device Design and Fabrication 
Microchannels were made from PDMS because it is easy to fabricate, optically 
transparent, biocompatible, and permeable to gases.  The photomask used contained 
microchannels designed with various geometries including rectangular, hexagonal, and 
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circular chambers.  Each microchannel was 1-2 cm long and 100 μm high with widths 
varying from 400 μm to 1000 μm.  Negative photoresist, SU-8 2035 (Microchem 
Corporation) was spun onto a 2 inch x 2 inch borosilicate glass at an initial speed of 500 
rpm at 100 rpm/s for 10 seconds followed by additional spinning at 1400rpm – 300 rpm/s 
for 30 seconds.  Soft baking of photoresist was achieved on a hot plate at 65ºC for 5 
minutes and at 95ºC for 20 minutes.  UV exposure through a chrome mask was 
performed with approximately 500 mJ/cm2 of energy.  Post exposure baking on a hot 
plate at 65ºC for 1 minute and at 95ºC for 10 minutes was followed by development in 
SU-8 developer (Microchem Corporation) and cleaning in isopropanol.  The fabrication 
process yielded channels with a height of 100 µm on average over the entire channel 
length.  Once the master was fabricated, it was placed in a 3-inch plastic dish for standard 
PDMS replica molding.  PDMS (Sylgard 184, Dow Corning Corporation) was prepared 
in a 10:1 (prepolymer:curing agent) ratio, cast as desired, degassed to remove air bubbles 
and then cured at 80ºC in a convective oven for 1 hour.  After cooling to room 
temperature, the PDMS membrane was peeled off the mold, cut down to size and a sharp 
stainless steel metal tubing (0.02-inch inner diameter) was used to core holes through the 
PDMS to access the channels (Figure 6-1).  The PDMS membrane was then placed 
directly into a culture dish until it was ready for use.  10 microchannels were fabricated 
for use in each experiment. 
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Figure 6-1. Fabrication process flow for photolithography and PDMS replica molding of cell culture 
microchannels and picture of device. 
 
Device Preparation 
 
Sterilization of our microhannels was achieved by placing them in isopropanol 
and slightly agitating in an ultrasonic bath.  This step was followed by placing the device 
in a sterile cell-culture hood under a 15 minute UV treatment.  The microchannels were 
then brought in direct contact with collagen-coated tissue culture dishes, and the 
interfacial property of PDMS allowed it to stick reversibly to the bottom of the dish.  
Subsequently, the microchannels were rinsed with 1X phosphate buffered saline (PBS) 
solution.  To deliver fluid into the microchannels, we used a similar method as described 
previously by Walker et al [19].  Briefly, a 10 µl pipette tip containing the fluid was 
placed directly over one well and a small droplet was delivered until it beaded out onto 
the top of the device.  Another pipette was then placed over the second well and suction 
was applied to pull the fluid through the microchannel.  Once the channel surfaces were 
UV light 
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wet, subsequent fluidic delivery was achieved via capillary action.  After rinsing with 
PBS, the device was kept aside until it was ready for use. 
 
Cell Isolation and Culture 
 
Primary rat hepatocytes were isolated from 7-10 weeks-old Sprague-Dawley rats 
as previously described [26].  The rat liver was initially perfused with a calcium-free 
buffer, followed by perfusion with a collagenase-containing buffer to separate 
hepatocytes from extracellular matrices.  The liver was then removed and hepatocytes 
were sedimented over a Percoll gradient.  Cells were cultured in William’s E medium 
supplemented with sodium pyruvate, 2mM L-glutamine, 0.1xITS-X (insulin at 1 μg/ml), 
hydrocortisone (0.5 mg/ml), 5 ng/ml EGF, and gentamicin.  Following isolation and 
purification, the suspension containing approximately 4x105 cells was centrifuged at 
1000 rpm for 2 minutes and the cell pellet was then resuspended in 300 μl of medium.  
Microchannels were inoculated by extracting 10 μl of cell suspension with a pipette and 
delivering it into each microchannel.  No suction was applied to the microchannels in 
order to minimize the shear stresses on the cells; therefore, the cell suspension was pulled 
through the microchannels by capillary action.  PRH medium was poured onto the bottom 
of the plastic dish in areas outside the PDMS membrane to prevent evaporation of media 
from the microchannels.   
HepG2 cells were obtained from the American Type Culture Collection 
(Manassas, VA) and cultured on collagen-coated 10-cm-diameter tissue culture plates in 
Minimal Essential Medium (MEM) supplemented with 10% fetal bovine serum, 
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nonessential amino acids, 1 mM sodium pyruvate, 2mM L-glutamine, and 5µg of 
gentamicin per ml.  Cells were maintained in incubators at 37ºC in 5% CO2 and medium 
was replaced every 2-3 days.  When the cells became confluent, 1 ml trypsin was added 
for 5 minutes in order to detach the cells from the plate and get single cell suspension.  
An additional 10 ml of HepG2 culture medium was added to stop the trypsin digestion 
followed by centrifugation at 1100 rpm for 3 minutes.  To get an 80% confluent layer of 
HepG2 cells in the microchannels 24 hours after plating, the cell pellet was resuspended 
in 300 µl of HepG2 medium and suspension was thoroughly mixed to break up pellet and 
ensure an even distribution.  The microchannels were then inoculated by extracting 20 µl 
of cell suspension with a pipette and delivering it into the microchannel.  The suspension 
filled the microchannels via capillary action and HepG2 medium was poured onto the 
bottom of the plastic dishes to minimize evaporation.   
 
RNA Isolation and RT-PCR Analysis 
 
 Reverse transcription-polymerase chain reaction (RT-PCR) analysis was used to 
identify liver-specific mRNA transcripts in primary rat hepatocytes cultured in 
microchannels for 96 hours.  The cells were washed in 1x PBS and gently scraped off the 
plastic substrates following removal of the PDMS housing.  Cell suspension was then 
transferred to an Eppendorf tube and centrifuged at 2000 rpm for 2 minutes and the pellet 
was stored at -80˚C until it was ready for RNA extraction.  Total RNA was isolated from 
the cells using TRIzol Reagent (Invitrogen, Life Technologies, USA) according to the 
manufacturer’s directions.  Following cell lysis in TRIzol reagent, chloroform was added 
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to the tubes and the suspension was centrifuged at 14,000 rpm for 30 minutes to separate 
out the RNA.   500 μl of isopropanol was used to precipitate the RNA followed by 
washing in 500 μl of 70% ethanol.  After decanting the ethanol, tubes were air-dried and 
pellet was then resuspended in RNAse and DNAse free water. As a positive control, the 
total RNA of freshly isolated unplated primary hepatocytes was also obtained.  Total 
RNA, previously treated with RNase-free DNase I was used for the RT-PCR.  RT was 
performed with the iScript cDNA synthesis Kit (Bio-Rad) containing 4 μl of 5x iScript 
reaction mix, 13 μl of nuclease-free water, 2 μl of the isolated RNA, and 1 μl of iScript 
reverse transcriptase.  Samples were incubated in a Thermocycler (Eppendorf) using the 
following program: 5 min at 25˚C followed by 30 min at 42˚C and 5 min at 85˚C.  
Several proteins have been previously reported as liver-specific markers and excellent 
indicators of the differentiated phenotype of hepatocytes; detection of their mRNA 
transcripts by RT-PCR has been used as a diagnostic test of hepatocyte differentiated 
status.  Hepatocyte nuclear factor 4 (HNF-4), transferrin (TFN), and albumin (ALB) are 
such markers [42].   The gene-specific primers for these proteins are listed in Table 6-1.  
Two microliters of the RT product were amplified in 48 μl of PCR solution containing 25 
μl of 2x PCR master mix (PCR buffer, MgCl2, dNTPs, Taq DNA polymerase), 1 μl of 
each DNA primer (forward and reverse), and 21 μl of deionized water.  PCR was 
performed in a programmable thermal cycler (Eppendorf) with the following 
amplification profile: 4 min at 95ºC followed by 30 cycles at 94ºC for 1 min, 55ºC for 1 
min and 72ºC for 1 minute.  The product was 530 bp for TF, 914 bp for ALB, and 770 bp 
for HNF-4.  PCR controls to detect contamination consisted of original isolated RNA not 
reverse transcribed added to the PCR mixture instead of RT mix and a water control was 
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interspersed between samples.  20 μl of the amplified product was electrophoresed on a 
1.5% agarose gel.  Bands of the appropriate size were visualized under UV light after 
ethidium bromide staining.  Each sample was analyzed and read as positive or negative.  
Positive and negative controls were run in parallel with our assay. 
 
Table 6-1 Sequences of reverse-transcriptase polymerase chain reaction primers to 
identify liver specific mRNA transcripts. 
 
Primer Sequence (5’-3’) Size, 
bp 
Cycle 
    
Albumin GCCGAAAACTGTGACAAGTC 914 30 
 TCTCGTAAAGCTCACAGTTAG   
HNF-4 CGGGCCACTGGCAAACAC 770 30 
 GTAATCCTCCAGGCTCACC   
Transferrin GGCTCAGGAACACTTTGGC 530 30 
 GTTGTTCCAGTTGATGCTGG   
 
 
DNA Transfection Protocol 
 
Plasmid constructs containing a greater-than-unit length cDNA of the HBV 
genome have been previously described [27-29].  Primary hepatocytes were transfected 
with 0.6 µg of HBV genome and 0.6 μg of enhanced green fluorescent protein (E-GFP) 
plasmid (for in-situ visualization) by using Lipofectamine2000 (Invitrogen) as described 
by manufacturer, with the following modifications.  The transfection reagent was used at 
a ratio of 2.4 µl to 1.2 µg of DNA and incubated for 20 min in 80 µl of PRH medium.  10 
μl of reagent was added to cells that had been plated the previous day on collagen-coated 
microchannels, and incubated for 5 hours.  After the incubation, the transfection medium 
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was removed and fresh PRH medium was added to the microchannels.  This method 
resulted in the transfection of approximately 10% of the PRH along the channel length.  
Transfection efficiency was determined by counting the number of GFP-positive cells in 
selected regions along the microchannel and dividing by the total number of cells in that 
region.  An average value is then calculated and used as the determined efficiency.  A 
similar transfection protocol was used for HepG2 cells with the following modifications.  
HepG2 cells at 60 - 80% confluency were transfected with 0.05 µg of HBV-cDNA 
genome and 0.05 μg of E-GFP plasmid by using Fugene 6 (Roche) as described by 
manufacturer.  The transfection reagent was used at a ratio of 0.3 µl to 0.1 µg of DNA 
and incubated for 30 min in 10 µl of serum-free, antibiotic-free HepG2 medium.  The 
mixture was added directly to cells that had been plated the previous day on collagen-
coated microchannels, and incubated overnight at 37ºC.  The following day, the 
transfection medium was removed, cells were washed gently with HepG2 medium, and 
fresh HepG2 medium containing antibiotics was added to the microchannels.  This 
method reproducibly resulted in the transfection of at least 40% of the HepG2 cells along 
the entire channel length.  Supernatants from HepG2 cells were collected at 4 days and 
analyzed for viral secretion. 
 
Adenovirus Infection of Primary Hepatocytes 
 
Recombinant adenoviruses that encode the HBV genome (AdHBV) were created 
using the AdEasy system (Stratagene) according to the manufacturer’s directions 
(Bouchard; unpublished data).  In order to support HBV replication, a cDNA that is 
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130 % (1.3mer) of the genome was cloned into the replication defective adenovirus.  
Starting at nucleotide 1411, the cDNA extends around the genome and then past 
nucleotide 1411, terminating at nucleotide 2327.  It has been previously shown in macro-
scale cultures that a recombinant adenovirus containing this or a similar cDNA of HBV 
can recapitulate all steps of HBV viral replication and bypasses the necessity of a species-
specific HBV receptor for HBV infection of hepatocytes [25, Bouchard; unpublished].  
The gene encoding GFP was also cloned into the HBV recombinant adenovirus (AdHBV) 
or a control recombinant adenovirus (AdGFP) to facilitate monitoring the efficiency of 
recombinant-adenovirus infections.  The recombinant adenoviruses were amplified in 
HEK 293 cells and high titer stocks were used for infection of PRH.  Cells were infected 
with the recombinant adenovirus at 80% confluency 24 hours after plating.  Virus stock 
aliquots containing the appropriate number of PFU to obtain the desired multiplicity of 
infection (MOI) were mixed with 20 μl of PRH media and added to cells.  After 1 hour at 
37ºC, additional PRH medium was added to the microchannels.  Culture media was 
changed daily for the duration of the experiment.  Supernatants from infected cells were 
collected and stored at – 80ºC until it was ready for PCR analysis.   
 
HBV Replication Assay 
 
HBV secreted from DNA-transfected or recombinant adenovirus infected cells 
was isolated and subjected to PCR for amplification of HBV DNA.  Supernatants 
collected from microchannels were subjected to a 5-minute centrifugation (1500 rpm) in 
microfuge to remove cellular debris.  This was followed by treatment with 1.5 μl of 
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RNASE A (10 mg/ml) and 1.5 μl of DNASE I (10 mg/ml) and a 10 second vortexing in 
centrifuge to mix.  Samples were then incubated for 45 minutes at 37ºC.  The following 
reagents were then added: 2 μl of 0.5 M EDTA, 10 μl of 10% SDS, 5 μl of proteinase K 
at 10 mg ml-1.  Samples were then centrifuged at 1500 rpm for 10 minutes.  0.2 μl of 3M 
sodium acetate (pH 4.8 -5.2) was added to sample and 400 μl of chilled 100% ethanol 
was added to precipitate HBV DNA.  Samples were kept at -20ºC for 20 minutes 
followed by an additional 15 minute centrifugation (1500 rpm).  Supernatant was 
discarded and 500 μl of 70% ethanol was used to gently wash pellet.  The pellet was left 
to air-dry and then resuspended in 25 μl of 1x TE (10mM Tris, 1 mM EDTA) buffer. 
 4 μl of extracted DNA were amplified in 21 μl of PCR solution containing 12.5 μl 
of 2x PCR master mix (PCR buffer, MgCl2, dNTPs, Taq DNA polymerase), 1 μl of each 
HBV-specific primers, forward primer (5’-
GCGATATCTCACTATTAGGCAGAGGTGAAAAAGTTGC-3’) and reverse primer  
(5’-GCGCGGCCGCATGGCTGCTAGGCTGTGC-3’), and 6.5 μl of deionized water.  
PCR was performed in the programmable thermal cycler with the following amplification 
profile: 4 min at 95ºC followed by 30 cycles at 94ºC for 1 min, 55ºC for 1 min and 72ºC 
for 1.5 minutes.  The product was 518 bp.  PCR controls to detect contamination 
consisted of deionized water added to the PCR mixture instead of DNA; negative 
controls containing 4 μl of deionized water instead of purified DNA and primers for 
ampicillin gene was used to demonstrate that the HBV positive result is not due to 
contamination with the original transfected plasmid which contains an ampicillin 
resistance region.  Primers used for the ampC negative controls were: ampC forward 
primer (5’-GGTCTGACAGTTACCAATGC-3’) and ampC reverse primer (5’- 
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GCTCACCCAGAAACGCTGG-3’).  The PCR product was 630 bp.  HBV positive 
control containing 1.5 μg/μl of DNA was also used and subject to the same PCR DNA 
amplification procedure as described above.  In addition, PCR controls used to detect 
contamination in supernatants collected from the adenovirus-infected PRH included 
primers to exclude detection of residual adenoviral genome.  Primers used were forward 
primer sequence (5’- CTGAATAAGAGGAAGTGAAATCTG-3’) and reverse primer 
sequence (5’- GGATTGCTGGTGGAAAGATTC-3’). 
 Following DNA amplification, 20μl of the amplified product was electrophoresed 
on a 2% agarose gel.  Bands of the appropriate size were visualized under UV light after 
ethidium bromide staining of the DNA.  Each sample was analyzed in duplicate and read 
as positive or negative.  Positive and negative controls were run in parallel with each 
assay. 
        
6.3 Results and Discussion 
Cell Culture in Microchannels 
 
Microscale cell culture has been previously demonstrated by many researchers 
[17-19, 21, 30, 43].    As with former reports, we also observed slower growth rates in 
our microchannels when either PRH or HepG2 cells were cultured in them.  Walker et al. 
[21] explained that the slower growth pattern observed in microchannel cell culture is 
likely a result of the cells being able to maintain a local microenvironment.  We also 
found that hepatocytes are particularly sensitive to shear stresses [30-31].  In order to 
reduce the shear stresses experienced by cells cultured in our microchannels, the 
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frequency of media replacement was reduced to once daily and this was sufficient to 
maintain viability while minimizing shear stresses on the underlying hepatocytes.  In 
addition, we found that applying suction during the initial delivery of cells into 
microchannels or during media changes resulted in the loss of hepatocytes; hence, we 
allowed the suspension to fill the microchannels via capillary action resulting in a lower 
force level and increased viability of hepatocytes (Figure 6-2).  Our cells were grown in 
static culture conditions using two sets of PDMS devices.  There were five microchannels 
per device and each device was visually monitored using an inverted microscope daily 
for cell viability, attachment, and proliferation.   
 
 
Figure 6-2. Effect of suction on primary rat hepatocytes culture.  Applying suction during cell culture 
results in shearing of hepatocyte cellular membrane and decreased cell viability. (a) PRH growing in a 
microchannel with no suction applied. (b) PRH morphology after applying suction. Scale bar: 100 µm 
 
 
No Suction Applied Suction Applied 
Hepatocytes removed due to shear 
force caused by suction. 
(a) (b) 
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In order to achieve confluent layers of hepatocytes in our microfluidic devices, we 
investigated several dilution volumes for resuspending cells before plating.  We found 
that resuspending a small pellet (approximately 4x105 cells) of primary rat hepatocytes in 
300 μl of media was sufficient to achieve 60 - 80% confluency in our microchannels 24 
hours after plating.  However, it is important to note that PRH have a tendency to stick to 
one another, so gentle pipetting of the suspension for an extended period allowed us to 
break apart the clumps.  Otherwise, cells tended to grow on top of one another and this 
multi-layer aggregation hindered the efficiency of the subsequent transfection and 
adenovirus infection steps (observation, data not shown).   
 
 
 
a) b) c) 
d) e) f) 
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Figure 6-3. Cell Culture in Microchannels (Standard bright-field Microscopy).  Cells were grown to 
approximately 80% confluency in microchannels as visualized under the microscope. (a-c) PRH cells 
cultured in microchannels for 96 hours remained viable and displayed normal morphology. (d-f) HepG2 
cells cultured in microchannels for 96 hours displayed normal morphology. Scale bar: 100 µm 
 
Figure 6-3(a-c) shows pictures of primary rat hepatocytes cultured in 
microchannels for 4 days and Figure 6-3(d-f) shows pictures of HepG2 cells cultured in 
microchannels for the same duration.  As can be seen from these pictures, cells displayed 
normal morphologies and formed a confluent monolayer within the microenvironment.  
Although the microchannels contained varying geometries, we did not observe any 
significant differences in the morphology of cells cultured in them.  If the cells were 
cultured under flow conditions, the channel geometries will affect the flow patterns and 
that may result in noticeable differences in the cell morphology.  A major concern with 
the use of primary hepatocytes for liver research is the loss of differentiated phenotype by 
cells even though the cells may remain viable during culture [10].  The differentiated 
attributes of primary hepatocytes are facilitated and maintained through the coordination 
of a series of liver proteins [32].   In order to ensure that the cells cultured in our system 
retained their liver-specific phenotype, we performed RT-PCR to identify liver-specific 
mRNA transcripts in primary hepatocytes cultured in our microchannels.  RT-PCR 
revealed that for the duration of our experiments (4 days), the cells expressed known 
hepatic differentiation markers such as transferrin, hepatocytes nuclear factor 4, and 
albumin; the same patterns and product intensities were observed with similar analyses of 
freshly isolated unplated primary hepatocytes (Figure 6-4).  Taken together, these results 
validate the use of our microchannels for cultures of both primary and established 
hepatocytes. 
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Figure 6-4. RT-PCR detection of hepatic RNA transcripts. Primary hepatocytes cultured in microchannels 
retain liver specific phenotype for 4 days. 1 DNA Ladder, 2 albumin (914bp) and transferrin (530bp) 
(combined PCR reaction), 3 negative control reaction using water, 4 hepatocyte nuclear factor-4 expression 
(770bp). RT-PCR analyses showed that hepatocytes in the microchannels retained expression of albumin, 
transferring, and HNF-4 mRNAs; the same patterns and product intensities were observed with similar 
analyses of freshly isolated rat hepatocytes (data not shown) 
 
Transfection of Hepatocytes 
A number of strategies are available for introducing DNA into eukaryotic cells 
including electroporation, microinjection, lipid-mediated transfections, and viral-
mediated delivery systems [25, 33-35].  Lipid-based transfections have been used 
successfully in macro-scale cell cultures and allows for delivery of genetic information in 
a variety of target cell types [24, 35].  In our experiments, we used cationic lipids such as 
Lipofectamine 2000 and Fugene 6 to deliver HBV DNA into PRH and HepG2 cells 
respectively.  According to the Fugene 6 manufacturers, transfection reagents can be 
   1    2   3    4 
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proportionally determined based on the total surface area of the cell culture vessel being 
used.  For example, in a 10 cm plate, 6 μg of DNA in 18 μl of transfection reagent was 
incubated in 600 μl of serum-free media.  Using this same approach, we calculated the 
total surface area of our microchannels and determined the range of values to be 4 x 10-4 
cm2 to 0.1 cm2.  Since our microchannel surface areas were close in dimensions to the 
surface area of one-well of a 96-well plate (approximately 0.3 cm2), we used 
manufacturer recommended reagent volumes of 3:1 (transfection reagent : DNA) in 
culture media.  Using this protocol, we were able to achieve a high efficiency transfection 
of HepG2 cells at a rate of 40% comparable to transfection efficiency obtained in macro-
scale cultures (Figure 6-5) (unpublished observation). 
 
 
(a) (b) 
(c) (d) 
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Figure 6-5. Transfection of human hepatoblastoma cell line (HepG2). (a, c) HepG2 cells cultured in 
microchannels; (b,d) HepG2 cells transfected with GFP expression plasmid (fluorescence microscopy). 
Panels (a,b) and (c,d) represent the same cells. Scale bar: 100 µm) 
 
Using a similar approach, we developed protocols to transfect primary rat 
hepatocytes in our microfluidic chambers (Figure 6-6).  Although we tried different ratios 
of transfection reagent to DNA (1:4, 1:3, 1:2), we found that a transfection ratio of 1:2 
worked well without compromising the viability of our cells.  However, the transfection 
efficiency for PRH cells (approximately 10%) was much lower than that obtained for 
HepG2 cells.  There are several factors that may have contributed to this result. One is 
that primary cells are generally less receptive to transfection even in macro-scale systems 
[36-37].  Also, since the local microenvironment of cells in microchannels are maintained 
for longer periods, the toxicity of the lipid complex transfected into the primary cells 
resulted in the loss of some sensitive hepatocytes [38].  The transfection efficiencies that 
we obtained for both cell types are comparable (typically 40 – 60% for HepG2 and 10 – 
20% for PRH) to those achieved using macro-scale techniques (unpublished observation).  
Our results show that DNA transfections can be performed in a microchannel setting with 
comparable results with macro-scale techniques. 
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Figure 6-6. Transfection of Primary Rat Hepatocytes (PRH). (a) PRH in microchannel; (b) PRH 
transfected with GFP expression plasmid in microchannel (fluorescence microscopy); Panels (a) and (b) 
represent the same cells. Scale bar: 100 µm 
 
Viral Replication and Detection via PCR 
Over the past fifteen years, researchers have revealed that established hepatocyte 
cell lines were capable of producing viral particles when transfected with HBV DNA [39-
40].  The ability to detect replicated viruses in these model systems has proven very 
useful for studies involving HBV infection and pathogenesis.  Once the cell is transfected, 
the viral-genome cDNA serves as a template for viral transcription; HBV replication 
occurs and the virus is secreted from the cells into the supernatants.  Typically, in 
traditional cell culture systems, viral replication studies are performed by either 
concentrating secreted viruses from a large volume of supernatant or cells are directly 
harvested and lysed to capture resident viral particles.  These assays, although very useful, 
are not convenient for studies in microchannels as only a few number of cells are 
available.  Polymerase chain reaction techniques including RT-PCR provide the 
capability for the sensitive identification, amplification, and quantification of nucleic 
(a) (b) 
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acids such as RNA and DNA in small sample volumes containing even very low amounts 
of targets [41].  Taking advantage of this technology, replicated HBV genome can be 
detected without performing cell lyses. 
Supernatants collected from our microchannels were used to isolate secreted HBV 
DNA, which was subsequently subjected to PCR analysis.  HBV DNA positive samples 
obtained after PCR amplification were visualized directly in ethidium bromide-stained 
agarose under UV illumination.  Initially, we used supernatants collected from 
transfected HepG2 cells to detect secreted HBV.  Although, we were able to detect 
secreted HBV from HepG2 cells, we were unable to detect replicated HBV in 
supernatants collected from transfected primary hepatocytes (data not shown).  These 
results of previous studies suggest that a transfected HBV cDNA yields lower levels of 
replicated HBV in PRH than HepG2 cells [28].  The low transfection efficiency coupled 
with the low level of replication in PRH may have resulted in undetectable levels of 
secreted viral DNA.  Therefore, for the purposes of the replication assay, we effectively 
used recombinant adenovirus constructs to infect primary hepatocytes.  Our experiments 
resulted in greater than 80% infection rate as verified by fluorescent microscopy showing 
GFP positive cells Figure 6-7.  Supernatants collected from infected cells were then used 
to detect replicated HBV. 
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Figure 6-7. Adenoviral Infection of Primary Rat Hepatoctyes. PRH were infected with adenoviruses that 
encode the HBV genome and expressed GFP. (a,c) phase contrast images of PRH cells infected with Ad-
HBV-GFP and (b,d) fluorescent image of same cells showing GFP expression. Scale bar: 100 µm 
 
In order to ensure that we were indeed detecting secreted HBV, we used primers 
specific for regions on the HBV plasmids used during transfection to eliminate foreign 
DNA contamination and as we can see from Figure 6-8, the band for HBV in our sample 
(panel 5) corresponds to the band on the positive control (panel 2).  We were unable to 
see a band in the negative controls (panel 3-4).  Similarly, we used primers specific for 
the adenoviruses to exclude contamination of samples with recombinant adenovirus 
collected from infected primary hepatocytes.  As can be seen from Figure 6-9, the band 
(a) (b) 
(c) (d) 
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for HBV (panel 5) parallels the band on the positive control (panel 2).  Overall, these 
results validate the use of microchannel based cell culture platforms for HBV replication 
assays.  
 
Figure 6-8. PCR detection of HBV Replication in HepG2 Cells: 1 Control reaction: PCR primers to detect 
contamination with transfected plasmid (ampC 630bp); 2 control reaction: PCR primers to HBV genome 
(HBV 518bp), amplification of control plasmid sequence; 3 PCR amplification of supernatant with plasmid 
control primers; 4 PCR amplification of supernatant with HBV specific primers. 
 
    1     2     3    4    5 
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Figure 6-9. PCR detection of HBV Replication in Primary Rat Hepatocytes. I Control reaction: PCR 
primers to detect contamination with transfected plasmid; 2 PCR amplification of supernatant with HBV 
specific primers (518bp); 3 λ-hindIII DNA ladder; 4-5 PCR amplification of supernatant with plasmid 
control primers; 6-7 control reaction: PCR primers to ad-HBV genome (3200bp), amplification of control 
plasmid sequence; 8-9 water (negative control) using control primers. 
 
6.4 Conclusion 
We have successfully demonstrated a microfluidic based in vitro assay for 
studying HBV replication.  This assay is necessary as an initial step towards the 
development of miniaturized model systems to study HBV replication using primary 
human hepatocytes.   We present here successful protocols to culture and transfect both 
primary rat hepatocytes and established human cell lines with HBV using 
microfabricated culture channels.  Moreover, we were able to detect newly replicated 
HBV in our micro chambers by simply using PCR amplification of isolated DNA from 
supernatants of transfected or infected cells.  This method allows for monitoring of HBV 
replication without the need for cell lysis.  We believe that this platform can be easily 
1    2  3   4   5   6   7   8  9 
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extended to studies involving viral transfections of primary human hepatocytes as only a 
small of sample of cells will be required for studies in microfluidic devices.   
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CHAPTER 7.  SUMMARY, CONCLUSIONS, AND FUTURE PROSPECTS 
In this thesis, techniques and tools were developed to address the need for in vitro 
cultivation models that capture various aspects of cell and cancer biology using 
microfabrication and microfluidics technology.  The fundamental reasoning for using 
these approaches and length scales is: (1) to facilitate assay miniaturization, (2) to more 
accurately mimic and control the cellular microenvironment, (3) to enable unprecedented 
experiments (e.g. single cell analysis and selective cellular treatment), (4) to reduce 
required biological samples especially cells of human origin, and (5) to increase the 
throughput of experimentation.   With the underlying foundation that micro-engineering 
techniques could be used to facilitate and improve cell-based experiments, the objective 
of this thesis was to develop tools to control the various microenvironmental parameters 
with emphasis on making tools that can be easily used by biological laboratories.  This 
thesis was divided into two main sections, each of which focused on a particular aspect of 
combining microfabrication with cell cultivation techniques: (1) the development of a 
miniaturized 3D culture platform that supports single breast cancer cell morphogenesis, 
migration, and invasion, and (2) exploring the development of a miniaturized liver model 
system for general liver biology study as well as viral-mediated liver cancer studies. The 
results and conclusions are summarized in this chapter, followed by recommendations for 
additional work.  
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7.1 Summary and Conclusions 
The first section of the thesis aimed to address the need for 3D cell-based models 
that can support normal cell development in a physiological context and enable easy 
parallelization for high-throughput screening of genes and targeted therapeutics.  To 
address this need, we took a miniaturization approach using microfabrication technology 
and developed a platform containing an array of micropatterned Matrigel to serve as 
housing for individual breast cells during 3D cell culture.  We developed techniques to 
create micropatterns of Matrigel using soft lithography techniques such as microtransfer 
molding and dry lift-off.  We found that surface treatment of PDMS with oxygen plasma 
and modification with poly-HEMA was sufficient to promote the deformation-free 
release of Matrigel patterns.  In addition, we were successful in developing a novel dual-
layer dry lift-off technique that allowed us to simultaneously pattern two different 
materials for example, Matrigel and poly-HEMA on a single substrate.  More importantly, 
we successfully demonstrated the utility of the micropatterned Matrigel in supporting the 
3D culture of normal and breast cancer cell lines with comparable phenotypes to standard 
3D culture techniques.   
We built on this accomplishment by developing a platform to study another aspect 
of cancer biology, which involves the dissemination of cancer cells from their tissue of 
origin to form new cancers in secondary organs.  We combined the micropatterned 
Matrigel with a microfluidic channel to impose concentration gradients of growth factors 
on breast cancer cells and successfully characterized the movement of the cells towards 
the growth factor gradient.  Our belief is that these platforms can be adapted for use with 
co-culture models involving complementary cell types, automated high-throughput 
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screening, or potentially combined with other microfluidic devices that will allow for 
selective screening.    
The second section of this thesis focused on the need for authentic liver models 
that can recreate the architecture and cellular content of a functional liver unit but only 
require a small number of cells so that it is applicable to studies involving normal human 
liver cells.  Our initial proof of concept experiments involved developing a simple 
microchannel platform that can be used to culture and maintain primary cells and 
established cell lines.  Protocols were developed to isolate and culture primary rat 
hepatocytes and liver sinusoidal endothelial cells in the microchannels.  Cells cultured in 
the microchannels displayed normal liver phenotype through the retention of liver 
specific mRNA transcripts.   
The microchannel based model was then successfully used as a platform to study 
hepatitis B viral replication in situ without the need for cell lysis.  We then built on this 
model by integrating the similar cell types found in the liver, i.e. the hepatocytes and 
endothelial cells in a microfluidic platform in order to mimic the hepatic sinusoid (basic 
functional unit of the liver).  The platform was composed of a microchannel housing 
monolayers of hepatocytes and endothelial cells separated by a matrix component.  The 
liver cells cultivated in this configuration retained their normal morphology and remained 
viable for more than 30 days.  The future goal of this project is to develop a new human 
liver model system that uses microfabrication and microfluidics technology to recreate 
the normal cellular, architectural, and fluidic environment of the liver sinusoid for 
studying various aspects of liver biology. 
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7.2 Research Contribution 
Several pioneering researchers in the field of cancer biology have popularized the 
concept that the cancer cell context i.e. the cellular microenvironment is as important to 
tumor formation and progression as the cell itself [1-4].  This important observation has 
been validated in many areas of biological research both directly and indirectly related to 
cancer studies.  This framework was best supported by Dr. Mina J. Bissell, who 
elucidated the role of the extracellular matrix (ECM) and the cellular microenvironment 
in the regulation of key cell-tissue specific functions, particularly in breast cancer 
research [4].  This important shift in paradigm, recognizing the significance of the cell 
environment is the basis of this thesis.  The central goal of this thesis is to develop 
miniaturized technologies that transcend the limitations of conventional macroscopic 
two-dimensional culture systems, by approaching the native environment of cells in vivo 
through technologies that allow direct screening of cultivated cells with drugs and 
targeted therapeutics in an appropriate context.   
Through my research work, we have been able to validate important works by 
others that show that recapitulating the cellular microenvironment can promote the 
viability and retention of cell-tissue specific phenotype.  For example, we have been able 
to confirm that culturing mammary epithelial cells in the presence of a micropatterned, 
laminin rich extracellular matrix component resulted in the formation of cellular 
structures that closely resembles those found in vivo.  Another more significant 
contribution however, is that in this thesis, we have developed a way to help diminish the 
differences that exist between current cell-based drug screening assays and the in vivo 
conditions they wish to model.   
  
189
Most macroscale in vitro assays are typically homotypic, use immortalized cell 
lines, and are conducted on artificial two dimensional glass or plastic substrates [5].  In 
contrast, cells in vivo are bordered by other cell types and exist in complex three 
dimensional matrix environments that provide physical support and relevant signaling 
biomolecules [5].  These considerable differences are well recognized to have profound 
effects on pharmacology [5-7].  Previous demonstrations of microscale 3D cell systems 
include works by Dr. Sangeeta Bhatia, who demonstrated the encapsulation of liver cells 
within photopolymerizable hydrogels in order to create an organized 3D context for the 
cells [8-9].  More recently, Dr. Ali Khademhosseini developed a microfabricated 
platform made of poly (ethylene glycol) microwell arrays to provide a 3D framework for 
embryonic stem cell proliferation and differentiation [10-12].  These works were 
successful in controlling the spatial localization of cells within patterned 3D 
microenvironments and demonstrated the utilization of such systems for high-throughput 
experimentation. 
Our work in building microscale 3D culture platforms takes a different approach in 
that instead of just coating surfaces with thin layers of synthetic matrices, we take an 
approach that fully recapitulates standard 3D culture assays, where cells are totally 
embedded or overlayed with ECM to mimic the 3D microenvironment necessary to 
establish tissue-specific functions as well as mechanical and structural signals.  Our 
development of a microfabricated platform for studying breast cancer cells can not only 
recapitulate normal epithelial structure and function but can also allow for more detailed 
understanding of tissue dysfunction in disease states and provides a more realistic milieu 
for modeling therapeutic intervention. 
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This thesis has also contributed to the development of physiological models of the 
liver.  For many years now, liver-related research has been plagued by the lack of 
authentic liver models that can serve as platforms for understanding fundamental liver 
biology or can be used in therapeutic applications involving various disease processes 
[13].  Microscale technologies have been developed by many groups to create functional 
liver tissue models [14-18].   As an example, Dr. Sangeeta Bhatia has shown that co-
cultivation of hepatocytes with other cell types represent a better in vitro model for 
studying liver related functions [14-15]. Dr. Linda Griffith has also demonstrated the 
development of an in vitro perfused liver model that enables the formation and viability 
of hepatocellular aggregates (structures mimicking hepatic acini) [16].  Dr. Martin 
Yarmush has also studied various aspects of liver cell behavior utilizing flat plate 
bioreactors to impose oxygen gradients on hepatocytes [17].  More recently, Dr. Luke 
Lee demonstrated a liver model unit that mimics the sinusoidal architecture of the liver 
by packing primary hepatocytes in microchambers that prevents the direct exposure of 
the cells to fluidic flow unit [18].  These works have been successful in demonstrating 
long-term retention of liver cell viability and functions and provided important 
foundational tools in recreating ex-vivo liver units. 
Like other researchers, we have helped to clarify and characterize the relationship 
between homotypic and heterotypic cellular interactions.  For example, we have 
confirmed that hepatocytes, when co-cultivated with other cell types including non-
parenchymal cells remained viable for longer periods and retained a differentiated 
phenotype.  Unlike previous liver models that rely on the culture of hepatocytes alone or 
randomly co-culture hepatocytes with other cell types, we have developed a more 
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realistic model that recreates important aspects of the liver including the architecture, 
fluidic environment, and more importantly the cellular composition.  A significant benefit 
of our model like others previously developed is that since we only require a small 
number of cells in our microdevices, we can perform experiments utilizing cells of 
human origin to capture pathologies and responses to therapy that cannot be done using 
current systems.  For example, the loss of liver cells susceptibility to hepatitis infection 
and many aspects of drug metabolism when they are placed in culture.  Our authentic 
liver models can not only recreate normal liver microenvironment but provides a great 
benefit to the pharmaceutical industry that is desperately in need of better liver models in 
the therapeutic screening of genes and drugs. 
 
7.3 Future Prospect 
Project Specific Outlook: 
Compatibility with HTS/HCS Systems 
 While we have been able to successfully miniaturize 3D epithelial culture assays, 
we have yet to demonstrate their utility for large-scale robotic screening.  In order to do 
this, we must modify our existing design so that it is compatible with high throughput 
screening (HTS) and high content screening systems (HCS).  The fabrication methods 
developed in this thesis can be easily adapted for use in industry (SBS-standard) multi-
well format (e.g. 24-well or 96-well format).  For example, the fabrication of PDMS 
membranes with through-holes can be modified such that the membranes can be easily 
inserted into the bottom of a multi-well plate (Figure 7-1).  The through-hole inserts 
within a multi-well plate can provide control over size, position, and the number of 3D 
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cell cultures, with the additional benefit of an automation friendly design that is 
compatible with HCS/HTS assay requirements.  Since PDMS membranes are optically 
transparent, the modified design will also support in situ microscopy and 
colorimetric/fluorescent plate-reader assays.  This approach should be beneficial for drug 
screening applications aimed at reducing costs, increasing the probability of clinical 
success, and limiting human exposure to unsafe drugs. 
 
Figure 7-1.  Image showing a schematic representation of a robotic screening system (adapted from 
http://www.metprog.org.uk/images/manufacturing_icon.jpg) using a high-throughput format screen of a 
96-well plate adapted for use with PDMS through-hole membranes to screen 3D cellular spheroids. 
 
Co-cultivation with Other Cell types 
Epithelial cancer cells reside in a well organized 3D microenvironment that is 
composed of many different cell types.  For example mammary epithelial cancer cells in 
vivo are surrounded by myoepithelial cells, adipocytes, and stromal fibroblasts (Figure 
7-2).  The close relationship between epithelial cells and stromal cells is not only a 
requirement for the maintenance of normal tissue architecture and organization, but is 
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also critical for epithelial cell morphogenesis and pathogenesis [19-21].  For example, 
stromal fibroblasts have been shown to influence the development of mammary epithelial 
cancers and their progression to a metastatic phenotype [20-21].  Currently, our platforms 
have been designed to investigate the relationship between epithelial cells and the 
surrounding extracellular matrix.  With only a few modifications, we can easily adapt 
these platforms to incorporate stromal cells such as fibroblasts (Figure 7-3).  We can 
analyze the influence of fibroblasts on epithelial cell morphogenesis by comparing 
relative growth rates in the presence or absence fibroblasts.  We can also investigate the 
influence of fibroblasts on invasive properties such as migration and matrix degradation.  
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Figure 7-2. Schematic Representation of Breast Tissue Environment and Architecture adapted from the 
Cancer Council Victoria, Australia 
(http://www.cancervic.org.au/cancer1/prevent/breasthealth/dcis.htm) 
 
 
 
 
Figure 7-3. Schematic Representation of Modification to existing platforms to include co-culture models 
 
Integration with Perfusion Systems 
 Microfluidic perfusion is often used to facilitate the cultivation of various cell 
types in vitro.  For example, continuous perfusion of liver cells is performed to promote 
long-term cell viability.  Other microfluidic perfusion systems use high levels of flow 
rates and shear stress to investigate endothelial cell function.  The mini-liver model that 
we are developing can be divided into two main facets: a co-culture domain and a 
nutrient transport domain.  While we have made significant progress in the co-culture 
aspect, work is still required for the nutrient transport portion.  Future work here includes 
incorporation of a perfusion system to effectively deliver nutrients and important bio-
compounds to cells and to remove toxic wastes such as bile.  Design improvements for 
the perfusion system should take into consideration several factors such as the 
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requirement of a threshold shear stress for endothelial cell alignment and morphology [22] 
as well as the sensitivity of hepatocytes to direct shear stress exposure [23].   
Gradients of nutrients, growth factors, and oxygen are an important aspect of liver 
biology.  With the perfusion system, some design modifications may be required to 
facilitate various biochemical gradients.  For example, we can take advantage of PDMS 
permeability properties to generate concentration gradients of oxygen and CO2 within the 
microchannels or we can directly incorporate an in-line oxygen gradient generator [24].  
The selection of the appropriate fluidic delivery system is also important.  Microfluidic 
perfusion can be achieved using a variety of mechanisms including gravity, external 
syringe pumps, or on-chip peristaltic pumps.  While gravity-based systems provide 
simplicity and constant flow rates, they may not be suitable for applications requiring 
precise control of flow rates and shear stress.  Syringe pumps may be a suitable 
alternative as they facilitate precise delivery of small volume flow rates.  Pressure within 
these systems is controlled to maintain flow rates in spite the fluidic resistance. 
 
Integration with Other Microfluidic Components 
 A unique advantage of microfluidic devices that has not been explored in this 
thesis is the capability to generate multiple laminar streams [25].  These parallel laminar 
streams can contain different fluids positioned over different regions of the cell or culture 
area.  This technique provides advantages for treating parts of the surface of a cell or a 
selected region with different biochemical reagents (Figure 7-4).  The selective delivery 
of a chemical to a localized portion of cells can be important for probing many biological 
questions.  For example trypsin can be selectively delivered to a certain region on the cell 
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surface to detach that portion of the cell while leaving the remaining part of the cell intact.  
Mammary acini growing on micropatterned Matrigel can be selectively exposed to a drug 
or compound and then detached for analysis.  This selective drug delivery and sampling 
can facilitate some interesting experiments.  For example, we can capture cells and 
examine markers of apoptosis during morphogenesis.  We can also test multiple 
compounds simultaneously and sample cells for expression of specific biomarkers for 
drug efficiency. 
 
 
Figure 7-4. Schematic Representation of a Selective laminar streaming system to directly probe different 
portions of the cell culture platform 
 
Advanced Numerical Modeling 
The numerical modeling approach developed in this thesis does not take into 
consideration interactions of cells with the surrounding matrix.  Cell migration is a very 
Selective Drug 
Delivery/Screening 
Multiple laminar streams 
  
197
complicated biological process that requires a coordination of both biochemical signaling 
pathways and physical locomotory processes.  The modeling of cell migration 
mechanisms requires an in-depth understanding of cellular interactions with the 
extracellular matrix and the physiochemical microenvironment.  However, this modeling 
approach adopted many simplifications so that further verification may be required.  
Experimental measurements of relevant transport properties such as diffusion coefficient 
in both the media domain and Matrigel region should be conducted.  The arbitrarily 
determined values for a and b should take into consideration important biological 
parameters such as cell-matrix dynamics that affect migration rates.  Also, the reaction 
kinetics that guides cell receptor distribution for EGF was not included in this modeling.  
In the future, this modeling approach should provide a more comprehensive physio-
chemical model that accounts for the various individual biophysical and biochemical 
processes involved in cell motility such as cell membrane (lamellipodia extension), 
formation of cell/matrix attachments, cell receptor-ligand kinetics, force transmission to 
the cell/matrix, and random cell motion (chemokinesis) [35]. 
  
General Future Prospects: 
Significant progress has been made in designing, controlling, recreating, and 
understanding various aspects of the cell microenvironment using microfabrication 
technology [26-34].  The benefit of integrating cells within miniaturized devices is the 
potential to transform the analytical throughput and experimental capabilities of 
biological laboratories in the coming years.  Researchers worldwide have demonstrated 
several applications of cell-based Microsystems ranging from analytical tools for cellular 
  
198
analysis within enhanced bioreactors to high-throughput drug/gene screening.  However, 
despite significant progress and desperate needs for such devices, many challenges still 
remain in fully capitalizing the potential of such technologies. 
While many MEMS-based tools have been developed, unfortunately, these devices 
have met limited reception in the biological community.  Conventional methods of 
performing experiments utilizing large-scale Petri dishes are limited in presenting 
functionalities relevant to cell culture and the number of experiments that can be 
performed.  Therefore, techniques that can facilitate assay miniaturization, functionalize 
various surfaces, micropattern cells and biomatrices, and facilitate the use of these 
techniques for high-throughput analysis will have significant medical and biological 
implications. 
To address the challenge in making MEMS devices widely applicable, we must 
overcome the general hindrances of incorporating new technologies into the biological 
research community.  One approach is to ensure adequate training of end users such as 
biologists, technicians, and clinicians on the capabilities and benefits of such devices in 
comparison to existing technologies.  Moreover, the fabrication processes of making 
these miniaturized devices must also be addressed.  Currently, most microfabricated 
devices are made in expensive clean rooms and microfabrication facilities.  These 
facilities require a very large initial project capital to install and can only be afforded by a 
few major research institutions.  Reducing the cost associated with the fabrication process 
will help to promote a more prevalent use of these devices.  Polymer-based 
micromanufacturing techniques such as soft lithography is a potentially useful approach 
of limiting the amount of fabrication time and cost by providing researchers with the 
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capability to fabricate devices directly in their own laboratories.  Successful 
commercialization of MEMs-based devices can also open new outlets to directly order 
devices without the need for fabrication. 
 Controlling the spatial organization of cells on surfaces within three-dimensional 
matrices is beneficial for the study of epithelial biology, utilization of cell-based devices, 
and even engineering ex vivo constructs.  Therefore, it is important for cell-based 
microdevices to incorporate a three-dimensional aspect into their design. Present micro-
scale approaches for cell handling and patterning are typically limited to homotypic 
cultures on two-dimensional substrates.  These platforms can be significantly improved 
by utilizing substrates that mimic the native extracellular matrix surrounding cells in vivo 
such as Matrigel and collagen. Overall improvements in the patterning material, the 
number of cells and proteins present, and the ability to pattern and generate three-
dimensional structures would provide great benefits for the utility of these systems. 
 While much progress has been made in the field, additional applications geared 
towards answering important and specific biological questions must be demonstrated. 
This task is especially suited for a new generation of researchers that are knowledgeable 
in engineering fundamentals and biological processes. 
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